KR20110010833A - Liquid crystal aligning agent and liquid crystal display device - Google Patents

Liquid crystal aligning agent and liquid crystal display device Download PDF

Info

Publication number
KR20110010833A
KR20110010833A KR1020110004497A KR20110004497A KR20110010833A KR 20110010833 A KR20110010833 A KR 20110010833A KR 1020110004497 A KR1020110004497 A KR 1020110004497A KR 20110004497 A KR20110004497 A KR 20110004497A KR 20110010833 A KR20110010833 A KR 20110010833A
Authority
KR
South Korea
Prior art keywords
liquid crystal
phenoxy
dione
naphtho
furan
Prior art date
Application number
KR1020110004497A
Other languages
Korean (ko)
Other versions
KR101032520B1 (en
Inventor
쇼우이찌 나까따
아쯔시 구마노
Original Assignee
제이에스알 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제이에스알 가부시끼가이샤 filed Critical 제이에스알 가부시끼가이샤
Publication of KR20110010833A publication Critical patent/KR20110010833A/en
Application granted granted Critical
Publication of KR101032520B1 publication Critical patent/KR101032520B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/52Liquid crystal materials characterised by components which are not liquid crystals, e.g. additives with special physical aspect: solvents, solid particles
    • C09K19/54Additives having no specific mesophase characterised by their chemical composition
    • C09K19/56Aligning agents
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G73/00Macromolecular compounds obtained by reactions forming a linkage containing nitrogen with or without oxygen or carbon in the main chain of the macromolecule, not provided for in groups C08G12/00 - C08G71/00
    • C08G73/06Polycondensates having nitrogen-containing heterocyclic rings in the main chain of the macromolecule
    • C08G73/10Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L79/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing nitrogen with or without oxygen or carbon only, not provided for in groups C08L61/00 - C08L77/00
    • C08L79/04Polycondensates having nitrogen-containing heterocyclic rings in the main chain; Polyhydrazides; Polyamide acids or similar polyimide precursors
    • C08L79/08Polyimides; Polyester-imides; Polyamide-imides; Polyamide acids or similar polyimide precursors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1335Structural association of cells with optical devices, e.g. polarisers or reflectors
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • G02F1/133Constructional arrangements; Operation of liquid crystal cells; Circuit arrangements
    • G02F1/1333Constructional arrangements; Manufacturing methods
    • G02F1/1337Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers
    • G02F1/133711Surface-induced orientation of the liquid crystal molecules, e.g. by alignment layers by organic films, e.g. polymeric films
    • G02F1/133723Polyimide, polyamide-imide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Nonlinear Science (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Mathematical Physics (AREA)
  • Health & Medical Sciences (AREA)
  • Optics & Photonics (AREA)
  • Engineering & Computer Science (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Materials Engineering (AREA)
  • Liquid Crystal (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Liquid Crystal Substances (AREA)

Abstract

PURPOSE: A liquid crystal alignment agent is provided to form a liquid crystal alignment agent with excellent vertical aligning property and to enable use for a vertically aligned liquid crystal display device. CONSTITUTION: A liquid crystal alignment agent includes a polymer having one or more structures selected from the group consisting of a structure of chemical formula 1 and a structure of chemical formula 2. In chemical formula 1, A^1 and B^1 are fluorine atoms. The polymer has a group represented by chemical formula 3: -P-Q-R^1-R^2, wherein P is a single bond, -O-, -COO- or -CONH-; Q is structures of chemical formula 1 or 2; R^1 is a divalent cycloaliphatic group; and R^2 is C1-22 linear alkyl group.

Description

액정 배향제 및 액정 표시 소자{Liquid Crystal Aligning Agent and Liquid Crystal Display Device}Liquid crystal aligning agent and a liquid crystal display device {Liquid Crystal Aligning Agent and Liquid Crystal Display Device}

본 발명은 액정 배향제 및 액정 표시 소자에 관한 것이다. 더욱 자세하게는 수직 배향형 액정 표시 소자 용도에 바람직한 수직 배향성을 갖는 액정 배향제 및 그것으로부터 얻어진 액정 배향막을 구비한 액정 표시 소자에 관한 것이다. The present invention relates to a liquid crystal aligning agent and a liquid crystal display element. More specifically, it relates to the liquid crystal aligning agent which has the perpendicular alignment property suitable for a vertical alignment type liquid crystal display element use, and the liquid crystal display element provided with the liquid crystal aligning film obtained from it.

현재, 액정 표시 소자로는 투명 도전막이 설치되어 있는 기판 표면에 폴리아미드산, 폴리이미드 등을 포함하는 액정 배향막을 형성하여 액정 표시 소자용 기판을 이루고, 그 두 장을 대향 배치하여 그의 간극 내에 양의 유전 이방성을 갖는 네마틱형 액정층을 형성하여 샌드위치 구조의 셀을 이루고, 액정 분자의 장축이 한쪽 기판에서 다른쪽 기판을 향해 연속적으로 90 도 비틀어지도록 한, 소위 TN형(Twisted Nematic) 액정 셀을 갖는 TN형 액정 표시 소자가 잘 알려져 있다. Currently, as a liquid crystal display element, a liquid crystal aligning film containing polyamic acid, polyimide, or the like is formed on the surface of a substrate on which a transparent conductive film is provided to form a substrate for a liquid crystal display element, and the two sheets thereof are disposed opposite to each other in the gap thereof. A so-called twisted nematic liquid crystal cell was formed by forming a nematic liquid crystal layer having dielectric anisotropy of ie, forming a sandwich cell, and causing the long axis of the liquid crystal molecules to be twisted 90 degrees continuously from one substrate to the other. The TN type liquid crystal display element which has is well known.

이에 대하여, 수직 배향형 액정 표시 소자는 유전 이방성이 음인 액정을 수직 배향시키고, 전압의 인가에 의해 액정 분자를 무너뜨려 동작시키는 것으로서, 시야각, 콘트라스트 등의 관점에서 우수하여 최근 활발히 연구 개발이 행해지고 있다. On the other hand, the vertically oriented liquid crystal display element vertically aligns liquid crystals having a negative dielectric anisotropy and breaks down the liquid crystal molecules by application of a voltage, and is excellent in terms of viewing angle, contrast, etc. .

여기서, 액정을 수직 배향시키기 위해서는 액정 배향막을 소수성으로 할 필요가 있고, 이 때문에 배향제 중에 소수성 성분(이하, 수직 배향 성분이라고도 함)을 다량으로 포함시킬 필요가 있다. 이러한 수직 배향 성분으로는, 통상 지방족, 지환족, 불소계의 관능기를 갖는 것이 이용되는 경우가 많다. 그러나 이러한 수직 배향 성분을 이용한 경우, 수직 배향의 안정성이 반드시 충분한 것은 아니라는 문제점이 있다.Here, in order to vertically align a liquid crystal, it is necessary to make a liquid crystal aligning film hydrophobic, and for this reason, it is necessary to contain a large amount of hydrophobic components (henceforth a vertical alignment component) in an aligning agent. As such a vertical orientation component, the thing which has an aliphatic, alicyclic, and fluorine-type functional group is normally used. However, when such a vertical alignment component is used, there is a problem that the stability of the vertical alignment is not necessarily sufficient.

따라서, 수직 배향의 안정성이 우수한 액정 배향제의 개발이 요망되고 있다.Therefore, the development of the liquid crystal aligning agent excellent in the stability of a vertical alignment is desired.

본 발명의 목적은 수직 배향의 안정성이 우수한 수직 배향형 액정 배향제를 제공하는 것에 있다.An object of the present invention is to provide a vertical alignment liquid crystal aligning agent having excellent stability of vertical alignment.

본 발명의 다른 목적은 본 발명의 액정 배향제로부터 얻어진 액정 배향막을 구비한 액정 표시 소자를 제공하는 것에 있다. Another object of the present invention is to provide a liquid crystal display device provided with a liquid crystal aligning film obtained from the liquid crystal aligning agent of the present invention.

본 발명의 또 다른 목적 및 이점은 이하의 설명으로 명백해질 것이다. Still other objects and advantages of the present invention will become apparent from the following description.

본 발명에 따르면 본 발명의 상기 목적 및 이점은, 첫 번째로 하기 화학식 1로 나타내지는 구조, 및 하기 화학식 2로 나타내지는 구조로 이루어지는 군으로부터 선택되는 1 개 이상의 구조를 측쇄에 갖는 중합체를 함유하는 것을 특징으로 하는 액정 배향제에 의해 달성된다.According to the present invention, the above objects and advantages of the present invention include a polymer having, in a side chain, at least one structure selected from the group consisting of a structure represented by the following general formula (1), and a structure represented by the following general formula (2). It is achieved by the liquid crystal aligning agent characterized by the above-mentioned.

Figure pat00001
Figure pat00001

식 중, A1 및 B1은 상호 독립적으로 수소 원자, 할로겐 원자 또는 시아노기이다. 단, A1 및 B1 중 1 개 이상은 할로겐 원자 또는 시아노기이다.In the formula, A 1 and B 1 are each independently a hydrogen atom, a halogen atom or a cyano group. Provided that at least one of A 1 and B 1 is a halogen atom or a cyano group.

Figure pat00002
Figure pat00002

또한, 본 발명의 상기 목적 및 이점은, 두 번째로 본 발명의 액정 배향제로 형성된 액정 배향막을 구비하여 이루어지는 것을 특징으로 하는 액정 표시 소자에 의해서 달성된다. Moreover, the said objective and advantage of this invention are achieved by the liquid crystal display element characterized by including the liquid crystal aligning film formed from the liquid crystal aligning agent of this invention second.

이하, 본 발명에 대해서 상세히 설명한다. EMBODIMENT OF THE INVENTION Hereinafter, this invention is demonstrated in detail.

본 발명의 액정 배향제는 상기 화학식 1로 나타내지는 구조, 또는 상기 화학식 2로 나타내지는 구조를 측쇄(이하, "특정 측쇄"라고도 함)에 갖는 중합체를 함유한다. 상기 화학식 1 중, A1 및 B1은 상호 독립적으로 수소 원자, 할로겐 원자 또는 시아노기이다. 단, A1 및 B1 중 1 개 이상은 할로겐 원자 또는 시아노기인 것으로 한다. 이러한 할로겐 원자로서는 구체적으로 불소 원자, 염소 원자, 브롬 원자 및 요오드 원자를 들 수 있다. 이 중, 불소 원자가 바람직하다. The liquid crystal aligning agent of this invention contains the polymer which has the structure represented by the said General formula (1), or the structure represented by the said General formula (2) in a side chain (henceforth "a specific side chain"). In Formula 1, A 1 and B 1 are each independently a hydrogen atom, a halogen atom or a cyano group. Provided that at least one of A 1 and B 1 is a halogen atom or a cyano group. As such a halogen atom, a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom are mentioned specifically ,. Among these, a fluorine atom is preferable.

상기 특정 측쇄로서는 구체적으로 하기 화학식 3으로 나타내지는 구조의 기를 들 수 있다. Specific examples of the specific side chain include groups having a structure represented by the following general formula (3).

Figure pat00003
Figure pat00003

상기 화학식 3에서의 P는 단결합, -O-, -COO- 또는 -CONH-이고, Q는 상기 화학식 1로 나타내지는 구조 또는 상기 화학식 2로 나타내지는 구조이다. 또한, 상기 화학식 3에서의 R1은 2가의 지환족기이다. 2가의 지환족기인 지환으로서 예를 들면, 보다 구체적으로는 시클로프로판환, 시클로부탄환, 시클로펜탄환, 시클로헥산환, 시클로헵탄환, 비시클로헥실환, 다시클로헥실환, 및 이들 환에 포함되는 1 개 또는 2 개 이상의 수소 원자가 알킬기, 아릴기, 알콕실기, 아릴록실기 등의 1가의 유기기, 또는 할로겐 원자에 의해 치환된 환을 들 수 있다. 또한, 상기 화학식 3에서의 R2는 탄소수가 1 내지 22인 직쇄상 알킬기이고, 바람직하게는 탄소수가 2 내지 18인 직쇄상 알킬기이고, 특히 바람직하게는 탄소수가 3 내지 10인 직쇄상 알킬기이다. P in the formula (3) is a single bond, -O-, -COO- or -CONH-, Q is a structure represented by the formula (1) or a structure represented by the formula (2). In addition, R 1 in the general formula (3) is a divalent alicyclic group. As an alicyclic which is a bivalent alicyclic group, For example, it is contained in a cyclopropane ring, a cyclobutane ring, a cyclopentane ring, a cyclohexane ring, a cycloheptane ring, a bicyclohexyl ring, a multicyclohexyl ring, and these rings more specifically. One or two or more hydrogen atoms to be mentioned are monovalent organic groups, such as an alkyl group, an aryl group, an alkoxyl group, an aryloxy group, or the ring substituted by the halogen atom. In addition, R <2> in the said General formula (3) is a C1-C22 linear alkyl group, Preferably it is a C2-C18 linear alkyl group, Especially preferably, it is a C3-C10 linear alkyl group.

이러한 특정 측쇄를 갖는 중합체의 골격 구조는 특별히 제한되지 않지만, 내열성 및 전기 특성이 우수한 점에서 폴리아미드산, 및 폴리아미드산을 탈수 폐환하여 얻어지는 이미드화 중합체인 것이 바람직하다. The skeleton structure of the polymer having such a specific side chain is not particularly limited, but is preferably an imidized polymer obtained by dehydrating and closing the polyamic acid and the polyamic acid from the viewpoint of excellent heat resistance and electrical properties.

상기 폴리아미드산은 하기 화학식 4로 나타내지는 디아민 (가)와 하기 화학식 5로 나타내지는 산무수물 (나)를 중축합함으로써 얻어진다. 또한, 상기 이미드화 중합체는 상기 폴리아미드산을 탈수 폐환함으로써 얻어진다. 본 발명의 액정 배향제에 이용되는 특정 측쇄를 갖는 폴리아미드산 및 이미드화 중합체의 합성에는 디아민 (가)와 산무수물 (나) 중 한쪽 이상에 특정 측쇄를 갖는 화합물이 사용된다. The polyamic acid is obtained by polycondensing the diamine (A) represented by the following formula (4) and the acid anhydride (B) represented by the following formula (5). In addition, the said imidized polymer is obtained by dehydrating and ring-closing the said polyamic acid. The compound which has a specific side chain in at least one of diamine (A) and an acid anhydride (B) is used for the synthesis | combination of the polyamic acid and imidation polymer which have a specific side chain used for the liquid crystal aligning agent of this invention.

Figure pat00004
Figure pat00004

식 중, Z1은 2가의 유기기를 나타낸다.In the formula, Z 1 represents a divalent organic group.

Figure pat00005
Figure pat00005

식 중, Z2는 4가의 유기기를 나타낸다.In the formula, Z 2 represents a tetravalent organic group.

상기한 특정 측쇄를 갖는 디아민 또는 산무수물의 사용 비율은 사용되는 전체 디아민 (가) 및 전체 산무수물 (나)의 합계에 대해, 1 내지 100 몰%인 것이 바람직하고, 5 내지 50%인 것이 보다 바람직하다. It is preferable that it is 1-100 mol% with respect to the sum total of the diamine or acid anhydride which has a specific side chain mentioned above with respect to the total diamine (a) and all the acid anhydride (b) used, and it is more preferable that it is 5-50%. desirable.

<디아민><Diamine>

특정 측쇄를 갖는 디아민으로서 구체적으로는 1-(2,3-디플루오로-4-(4-n-프로필시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디플루오로-4-(4-n-부틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디플루오로-4-(4-n-펜틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디플루오로-4-(4-n-헥실시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디플루오로-4-(4-n-헵틸시클로헥실)페녹시)-2,4-디아미노벤젠; Specific examples of the diamine having a specific side chain include 1- (2,3-difluoro-4- (4-n-propylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3- Difluoro-4- (4-n-butylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-difluoro-4- (4-n-pentylcyclohexyl) phenoxy C) -2,4-diaminobenzene, 1- (2,3-difluoro-4- (4-n-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2 , 3-difluoro-4- (4-n-heptylcyclohexyl) phenoxy) -2,4-diaminobenzene;

1-(2,3-디시아노-4-(4-n-프로필시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디시아노-4-(4-n-부틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디시아노-4-(4-n-펜틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디시아노-4-(4-n-헥실시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디시아노-4-(4-n-헵틸시클로헥실)페녹시)-2,4-디아미노벤젠; 1- (2,3-dicyano-4- (4-n-propylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-dicyano-4- (4-n- Butylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-dicyano-4- (4-n-pentylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1 -(2,3-dicyano-4- (4-n-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-dicyano-4- (4-n- Heptylcyclohexyl) phenoxy) -2,4-diaminobenzene;

(2,3-디플루오로-4-(4-n-프로필시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디플루오로-4-(4-n-부틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디플루오로-4-(4-n-펜틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디플루오로-4-(4-n-헥실시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디플루오로-4-(4-n-헵틸시클로헥실)페닐)-3,5-디아미노벤조에이트; (2,3-difluoro-4- (4-n-propylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-difluoro-4- (4-n-butylcyclo Hexyl) phenyl) -3,5-diaminobenzoate, (2,3-difluoro-4- (4-n-pentylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3 -Difluoro-4- (4-n-hexylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-difluoro-4- (4-n-heptylcyclohexyl) phenyl ) -3,5-diaminobenzoate;

(2,3-디시아노-4-(4-n-프로필시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디시아노-4-(4-n-부틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디시아노-4-(4-n-펜틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디시아노-4-(4-n-헥실시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디시아노-4-(4-n-헵틸시클로헥실)페닐)-3,5-디아미노벤조에이트; (2,3-dicyano-4- (4-n-propylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-dicyano-4- (4-n-butylcyclohexyl) Phenyl) -3,5-diaminobenzoate, (2,3-dicyano-4- (4-n-pentylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-dicyano -4- (4-n-hexylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-dicyano-4- (4-n-heptylcyclohexyl) phenyl) -3,5 -Diaminobenzoate;

1-(6-(4-n-프로필시클로헥실)-3-피리다지닐옥시)-2,4-디아미노벤젠, 1-(6-(4-n-부틸시클로헥실)-3-피리다지닐옥시)-2,4-디아미노벤젠, 1-(6-(4-n-펜틸시클로헥실)-3-피리다지닐옥시)-2,4-디아미노벤젠, 1-(6-(4-n-헥실시클로헥실)-3-피리다지닐옥시)-2,4-디아미노벤젠, 1-(6-(4-n-헵틸시클로헥실)-3-피리다지닐옥시)-2,4-디아미노벤젠; 1- (6- (4-n-propylcyclohexyl) -3-pyridazinyloxy) -2,4-diaminobenzene, 1- (6- (4-n-butylcyclohexyl) -3-pyrida Genyloxy) -2,4-diaminobenzene, 1- (6- (4-n-pentylcyclohexyl) -3-pyridazinyloxy) -2,4-diaminobenzene, 1- (6- (4 -n-hexylcyclohexyl) -3-pyridazinyloxy) -2,4-diaminobenzene, 1- (6- (4-n-heptylcyclohexyl) -3-pyridazinyloxy) -2, 4-diaminobenzene;

(6-(4-n-프로필시클로헥실)-3-피리다지닐)-3,5-디아미노벤조에이트, (6-(4-n-부틸시클로헥실)-3-피리다지닐)-3,5-디아미노벤조에이트, (6-(4-n-펜틸시클로헥실)-3-피리다지닐)-3,5-디아미노벤조에이트, (6-(4-n-헥실시클로헥실)-3-피리다지닐)-3,5-디아미노벤조에이트, (6-(4-n-헵틸시클로헥실)-3-피리다지닐)-3,5-디아미노벤조에이트; (6- (4-n-propylcyclohexyl) -3-pyridazinyl) -3,5-diaminobenzoate, (6- (4-n-butylcyclohexyl) -3-pyridazinyl) -3 , 5-diaminobenzoate, (6- (4-n-pentylcyclohexyl) -3-pyridazinyl) -3,5-diaminobenzoate, (6- (4-n-hexylcyclohexyl) -3-pyridazinyl) -3,5-diaminobenzoate, (6- (4-n-heptylcyclohexyl) -3-pyridazinyl) -3,5-diaminobenzoate;

1-(2-플루오로-4-(4-n-프로필시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2-플루오로-4-(4-n-부틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2-플루오로-4-(4-n-펜틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2-플루오로-4-(4-n-헥실시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2-플루오로-4-(4-n-헵틸시클로헥실)페녹시)-2,4-디아미노벤젠; 1- (2-fluoro-4- (4-n-propylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2-fluoro-4- (4-n-butylcyclohexyl) Phenoxy) -2,4-diaminobenzene, 1- (2-fluoro-4- (4-n-pentylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2-fluoro -4- (4-n-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2-fluoro-4- (4-n-heptylcyclohexyl) phenoxy) -2, 4-diaminobenzene;

1-(3-플루오로-4-(4-n-프로필시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(3-플루오로-4-(4-n-부틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(3-플루오로-4-(4-n-펜틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(3-플루오로-4-(4-n-헥실시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(3-플루오로-4-(4-n-헵틸시클로헥실)페녹시)-2,4-디아미노벤젠; 1- (3-fluoro-4- (4-n-propylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (3-fluoro-4- (4-n-butylcyclohexyl) Phenoxy) -2,4-diaminobenzene, 1- (3-fluoro-4- (4-n-pentylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (3-fluoro -4- (4-n-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (3-fluoro-4- (4-n-heptylcyclohexyl) phenoxy) -2, 4-diaminobenzene;

1-(2-시아노-4-(4-n-프로필시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2-시아노-4-(4-n-부틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2-시아노-4-(4-n-펜틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2-시아노-4-(4-n-헥실시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2-시아노-4-(4-n-헵틸시클로헥실)페녹시)-2,4-디아미노벤젠; 1- (2-cyano-4- (4-n-propylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2-cyano-4- (4-n-butylcyclohexyl) Phenoxy) -2,4-diaminobenzene, 1- (2-cyano-4- (4-n-pentylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2-cyano -4- (4-n-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2-cyano-4- (4-n-heptylcyclohexyl) phenoxy) -2, 4-diaminobenzene;

1-(3-시아노-4-(4-n-프로필시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(3-시아노-4-(4-n-부틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(3-시아노-4-(4-n-펜틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(3-시아노-4-(4-n-헥실시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(3-시아노-4-(4-n-헵틸시클로헥실)페녹시)-2,4-디아미노벤젠;1- (3-cyano-4- (4-n-propylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (3-cyano-4- (4-n-butylcyclohexyl) Phenoxy) -2,4-diaminobenzene, 1- (3-cyano-4- (4-n-pentylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (3-cyano -4- (4-n-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (3-cyano-4- (4-n-heptylcyclohexyl) phenoxy) -2, 4-diaminobenzene;

(2-플루오로-4-(4-n-프로필시클로헥실)페닐)-3,5-디아미노벤조에이트, (2-플루오로-4-(4-n-부틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (2-플루오로-4-(4-n-펜틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (2-플루오로-4-(4-n-헥실시클로헥실)페닐)-3,5-디아미노벤조에이트, (2-플루오로-4-(4-n-헵틸시클로헥실)페닐)-3,5-디아미노벤조에이트;(2-fluoro-4- (4-n-propylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2-fluoro-4- (4-n-butylcyclohexyl) phenyl) -3 , 5-diaminobenzoate, (2-fluoro-4- (4-n-pentylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2-fluoro-4- (4-n- Hexylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2-fluoro-4- (4-n-heptylcyclohexyl) phenyl) -3,5-diaminobenzoate;

(3-플루오로-4-(4-n-프로필시클로헥실)페닐)-3,5-디아미노벤조에이트, (3-플루오로-4-(4-n-부틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (3-플루오로-4-(4-n-펜틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (3-플루오로-4-(4-n-헥실시클로헥실)페닐)-3,5-디아미노벤조에이트, (3-플루오로-4-(4-n-헵틸시클로헥실)페닐)-3,5-디아미노벤조에이트;(3-fluoro-4- (4-n-propylcyclohexyl) phenyl) -3,5-diaminobenzoate, (3-fluoro-4- (4-n-butylcyclohexyl) phenyl) -3 , 5-diaminobenzoate, (3-fluoro-4- (4-n-pentylcyclohexyl) phenyl) -3,5-diaminobenzoate, (3-fluoro-4- (4-n- Hexylcyclohexyl) phenyl) -3,5-diaminobenzoate, (3-fluoro-4- (4-n-heptylcyclohexyl) phenyl) -3,5-diaminobenzoate;

(2-시아노-4-(4-n-프로필시클로헥실)페닐)-3,5-디아미노벤조에이트, (2-시아노-4-(4-n-부틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (2-시아노-4-(4-n-펜틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (2-시아노-4-(4-n-헥실시클로헥실)페닐)-3,5-디아미노벤조에이트, (2-시아노-4-(4-n-헵틸시클로헥실)페닐)-3,5-디아미노벤조에이트; (2-cyano-4- (4-n-propylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2-cyano-4- (4-n-butylcyclohexyl) phenyl) -3 , 5-diaminobenzoate, (2-cyano-4- (4-n-pentylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2-cyano-4- (4-n- Hexylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2-cyano-4- (4-n-heptylcyclohexyl) phenyl) -3,5-diaminobenzoate;

(3-시아노-4-(4-n-프로필시클로헥실)페닐)-3,5-디아미노벤조에이트, (3-시아노-4-(4-n-부틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (3-시아노-4-(4-n-펜틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (3-시아노-4-(4-n-헥실시클로헥실)페닐)-3,5-디아미노벤조에이트, (3-시아노-4-(4-n-헵틸시클로헥실)페닐)-3,5-디아미노벤조에이트를 들 수 있다. 이들 중에서, 1-(2,3-디플루오로-4-(4-n-프로필시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디플루오로-4-(4-n-부틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디플루오로-4-(4-n-펜틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디플루오로-4-(4-n-헥실시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디플루오로-4-(4-n-헵틸시클로헥실)페녹시)-2,4-디아미노벤젠; (3-cyano-4- (4-n-propylcyclohexyl) phenyl) -3,5-diaminobenzoate, (3-cyano-4- (4-n-butylcyclohexyl) phenyl) -3 , 5-diaminobenzoate, (3-cyano-4- (4-n-pentylcyclohexyl) phenyl) -3,5-diaminobenzoate, (3-cyano-4- (4-n- Hexylcyclohexyl) phenyl) -3,5-diaminobenzoate and (3-cyano-4- (4-n-heptylcyclohexyl) phenyl) -3,5-diaminobenzoate. Among them, 1- (2,3-difluoro-4- (4-n-propylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-difluoro-4- (4-n-butylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-difluoro-4- (4-n-pentylcyclohexyl) phenoxy) -2,4 -Diaminobenzene, 1- (2,3-difluoro-4- (4-n-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-difluoro -4- (4-n-heptylcyclohexyl) phenoxy) -2,4-diaminobenzene;

1-(2,3-디시아노-4-(4-n-프로필시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디시아노-4-(4-n-부틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디시아노-4-(4-n-펜틸시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디시아노-4-(4-n-헥실시클로헥실)페녹시)-2,4-디아미노벤젠, 1-(2,3-디시아노-4-(4-n-헵틸시클로헥실)페녹시)-2,4-디아미노벤젠; 1- (2,3-dicyano-4- (4-n-propylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-dicyano-4- (4-n- Butylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-dicyano-4- (4-n-pentylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1 -(2,3-dicyano-4- (4-n-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene, 1- (2,3-dicyano-4- (4-n- Heptylcyclohexyl) phenoxy) -2,4-diaminobenzene;

(2,3-디플루오로-4-(4-n-프로필시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디플루오로-4-(4-n-부틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디플루오로-4-(4-n-펜틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디플루오로-4-(4-n-헥실시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디플루오로-4-(4-n-헵틸시클로헥실)페닐)-3,5-디아미노벤조에이트; (2,3-difluoro-4- (4-n-propylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-difluoro-4- (4-n-butylcyclo Hexyl) phenyl) -3,5-diaminobenzoate, (2,3-difluoro-4- (4-n-pentylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3 -Difluoro-4- (4-n-hexylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-difluoro-4- (4-n-heptylcyclohexyl) phenyl ) -3,5-diaminobenzoate;

(2,3-디시아노-4-(4-n-프로필시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디시아노-4-(4-n-부틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디시아노-4-(4-n-펜틸시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디시아노-4-(4-n-헥실시클로헥실)페닐)-3,5-디아미노벤조에이트, (2,3-디시아노-4-(4-n-헵틸시클로헥실)페닐)-3,5-디아미노벤조에이트; (2,3-dicyano-4- (4-n-propylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-dicyano-4- (4-n-butylcyclohexyl) Phenyl) -3,5-diaminobenzoate, (2,3-dicyano-4- (4-n-pentylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-dicyano -4- (4-n-hexylcyclohexyl) phenyl) -3,5-diaminobenzoate, (2,3-dicyano-4- (4-n-heptylcyclohexyl) phenyl) -3,5 -Diaminobenzoate;

1-(6-(4-n-프로필시클로헥실)-3-피리다지닐옥시)-2,4-디아미노벤젠, 1-(6-(4-n-부틸시클로헥실)-3-피리다지닐옥시)-2,4-디아미노벤젠, 1-(6-(4-n-펜틸시클로헥실)-3-피리다지닐옥시)-2,4-디아미노벤젠, 1-(6-(4-n-헥실시클로헥실)-3-피리다지닐옥시)-2,4-디아미노벤젠, 1-(6-(4-n-헵틸시클로헥실)-3-피리다지닐옥시)-2,4-디아미노벤젠; 1- (6- (4-n-propylcyclohexyl) -3-pyridazinyloxy) -2,4-diaminobenzene, 1- (6- (4-n-butylcyclohexyl) -3-pyrida Genyloxy) -2,4-diaminobenzene, 1- (6- (4-n-pentylcyclohexyl) -3-pyridazinyloxy) -2,4-diaminobenzene, 1- (6- (4 -n-hexylcyclohexyl) -3-pyridazinyloxy) -2,4-diaminobenzene, 1- (6- (4-n-heptylcyclohexyl) -3-pyridazinyloxy) -2, 4-diaminobenzene;

(6-(4-n-프로필시클로헥실)-3-피리다지닐)-3,5-디아미노벤조에이트, (6-(4-n-부틸시클로헥실)-3-피리다지닐)-3,5-디아미노벤조에이트, (6-(4-n-펜틸시클로헥실)-3-피리다지닐)-3,5-디아미노벤조에이트, (6-(4-n-헥실시클로헥실)-3-피리다지닐)-3,5-디아미노벤조에이트, (6-(4-n-헵틸시클로헥실)-3-피리다지닐)-3,5-디아미노벤조에이트가 바람직하다. (6- (4-n-propylcyclohexyl) -3-pyridazinyl) -3,5-diaminobenzoate, (6- (4-n-butylcyclohexyl) -3-pyridazinyl) -3 , 5-diaminobenzoate, (6- (4-n-pentylcyclohexyl) -3-pyridazinyl) -3,5-diaminobenzoate, (6- (4-n-hexylcyclohexyl) 3-pyridazinyl) -3,5-diaminobenzoate and (6- (4-n-heptylcyclohexyl) -3-pyridazinyl) -3,5-diaminobenzoate are preferred.

본 발명의 액정 배향제에 함유되는 중합체의 합성에 이용되는 그 밖의 디아민으로는, 예를 들면 p-페닐렌디아민, m-페닐렌디아민, 4,4'-디아미노디페닐메탄, 4,4'-디아미노디페닐에탄, 4,4'-디아미노디페닐술피드, 4,4'-디아미노디페닐술폰, 3,3'-디메틸-4,4'-디아미노비페닐, 4,4'-디아미노벤즈아닐리드, 4,4'-디아미노디페닐에테르, 1,5-디아미노나프탈렌, 2,2'-디메틸-4,4'-디아미노비페닐, 5-아미노-1-(4'-아미노페닐)-1,3,3-트리메틸인단, 6-아미노-1-(4'-아미노페닐)-1,3,3-트리메틸인단, 3,4'-디아미노디페닐에테르, 3,3'-디아미노벤조페논, 3,4'-디아미노벤조페논, 4,4'-디아미노벤조페논, 2,2-비스[4-(4-아미노페녹시)페닐]프로판, 2,2-비스[4-(4-아미노페녹시)페닐]헥사플루오로프로판, 2,2-비스(4-아미노페닐)헥사플루오로프로판, 2,2-비스[4-(4-아미노페녹시)페닐]술폰, 1,4-비스(4-아미노페녹시)벤젠, 1,3-비스(4-아미노페녹시)벤젠, 1,3-비스(3-아미노페녹시)벤젠, 9,9-비스(4-아미노페닐)-10-히드로안트라센, 2,7-디아미노플루오렌, 9,9-비스(4-아미노페닐)플루오렌, 4,4'-메틸렌-비스(2-클로로아닐린), 2,2',5,5'-테트라클로로-4,4'-디아미노비페닐, 2,2'-디클로로-4,4'-디아미노-5,5'-디메톡시비페닐, 3,3'-디메톡시-4,4'-디아미노비페닐, 1,4,4'-(p-페닐렌이소프로필리덴)비스아닐린, 4,4'-(m-페닐렌이소프로필리덴)비스아닐린, 2,2'-비스[4-(4-아미노-2-트리플루오로메틸페녹시)페닐]헥사플루오로프로판, 4,4'-디아미노-2,2'-비스(트리플루오로메틸)비페닐, 4,4'-비스[(4-아미노-2-트리플루오로메틸)페녹시]-옥타플루오로비페닐 등의 방향족 디아민;As another diamine used for the synthesis | combination of the polymer contained in the liquid crystal aligning agent of this invention, p-phenylenediamine, m-phenylenediamine, 4,4'- diamino diphenylmethane, 4,4, for example. '-Diaminodiphenylethane, 4,4'-diaminodiphenylsulfide, 4,4'-diaminodiphenylsulfone, 3,3'-dimethyl-4,4'-diaminobiphenyl, 4, 4'-diaminobenzanilide, 4,4'-diaminodiphenylether, 1,5-diaminonaphthalene, 2,2'-dimethyl-4,4'-diaminobiphenyl, 5-amino-1- (4'-aminophenyl) -1,3,3-trimethylindane, 6-amino-1- (4'-aminophenyl) -1,3,3-trimethylindane, 3,4'-diaminodiphenylether , 3,3'-diaminobenzophenone, 3,4'-diaminobenzophenone, 4,4'-diaminobenzophenone, 2,2-bis [4- (4-aminophenoxy) phenyl] propane, 2,2-bis [4- (4-aminophenoxy) phenyl] hexafluoropropane, 2,2-bis (4-aminophenyl) hexafluoropropane, 2,2-bis [4- (4-amino Phenoxy) phenyl] sulfone, 1,4-bis (4- Minophenoxy) benzene, 1,3-bis (4-aminophenoxy) benzene, 1,3-bis (3-aminophenoxy) benzene, 9,9-bis (4-aminophenyl) -10-hydroanthracene , 2,7-diaminofluorene, 9,9-bis (4-aminophenyl) fluorene, 4,4'-methylene-bis (2-chloroaniline), 2,2 ', 5,5'-tetra Chloro-4,4'-diaminobiphenyl, 2,2'-dichloro-4,4'-diamino-5,5'-dimethoxybiphenyl, 3,3'-dimethoxy-4,4'- Diaminobiphenyl, 1,4,4 '-(p-phenyleneisopropylidene) bisaniline, 4,4'-(m-phenyleneisopropylidene) bisaniline, 2,2'-bis [4- (4-amino-2-trifluoromethylphenoxy) phenyl] hexafluoropropane, 4,4'-diamino-2,2'-bis (trifluoromethyl) biphenyl, 4,4'-bis Aromatic diamines such as [(4-amino-2-trifluoromethyl) phenoxy] -octafluorobiphenyl;

메타크실릴렌디아민, 1,3-프로판디아민, 테트라메틸렌디아민, 펜타메틸렌디아민, 헥사메틸렌디아민, 헵타메틸렌디아민, 옥타메틸렌디아민, 노나메틸렌디아민, 4,4-디아미노헵타메틸렌디아민, 1,4-디아미노시클로헥산, 이소포론디아민, 테트라히드로디시클로펜타디에닐렌디아민, 헥사히드로-4,7-메타노인다닐렌디메틸렌디아민, 트리시클로[6.2.1.02,7]-운데실렌디메틸디아민, 4,4'-메틸렌비스(시클로헥실아민) 등의 지방족 및 지환식 디아민; Methaxylylenediamine, 1,3-propanediamine, tetramethylenediamine, pentamethylenediamine, hexamethylenediamine, heptamethylenediamine, octamethylenediamine, nonamethylenediamine, 4,4-diaminoheptamethylenediamine, 1,4 -Diaminocyclohexane, isophoronediamine, tetrahydrodicyclopentadienylenediamine, hexahydro-4,7-methanoindenylenedimethylenediamine, tricyclo [6.2.1.0 2,7 ] -undecylenedimethyldiamine, 4 Aliphatic and alicyclic diamines such as 4'-methylenebis (cyclohexylamine);

2,3-디아미노피리딘, 2,6-디아미노피리딘, 3,4-디아미노피리딘, 2,4-디아미노피리미딘, 5,6-디아미노-2,3-디시아노피라진, 5,6-디아미노-2,4-디히드록시피리미딘, 2,4-디아미노-6-디메틸아미노-1,3,5-트리아진, 1,4-비스(3-아미노프로필)피페라진, 2,4-디아미노-6-이소프로폭시-1,3,5-트리아진, 2,4-디아미노-6-메톡시-1, 3,5-트리아진, 2,4-디아미노-6-페닐-1,3,5-트리아진, 2,4-디아미노-6-메틸-s-트리아진, 2,4-디아미노-1,3,5-트리아진, 4,6-디아미노-2-비닐-s-트리아진, 2,4-디아미노-5-페닐티아졸, 2,6-디아미노푸린, 5,6-디아미노-1,3-디메틸우라실, 3,5-디아미노-1,2,4-트리아졸, 6,9-디아미노-2-에톡시아크리딘락테이트, 3,8-디아미노-6-페닐페난트리딘, 1,4-디아미노피페라진, 3,6-디아미노아크리딘, 비스(4-아미노페닐)페닐아민 및 하기 화학식 6 내지 7로 나타내지는 화합물 등의, 분자 내에 2 개의 1급 아미노기 및 상기 1 급 아미노기 이외의 질소 원자를 갖는 디아민; 2,3-diaminopyridine, 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4-diaminopyrimidine, 5,6-diamino-2,3-dicyanopyrazine, 5, 6-diamino-2,4-dihydroxypyrimidine, 2,4-diamino-6-dimethylamino-1,3,5-triazine, 1,4-bis (3-aminopropyl) piperazine, 2,4-diamino-6-isopropoxy-1,3,5-triazine, 2,4-diamino-6-methoxy-1, 3,5-triazine, 2,4-diamino- 6-phenyl-1,3,5-triazine, 2,4-diamino-6-methyl-s-triazine, 2,4-diamino-1,3,5-triazine, 4,6-dia Mino-2-vinyl-s-triazine, 2,4-diamino-5-phenylthiazole, 2,6-diaminopurine, 5,6-diamino-1,3-dimethyluracil, 3,5- Diamino-1,2,4-triazole, 6,9-diamino-2-ethoxyacridine lactate, 3,8-diamino-6-phenylphenanthtridine, 1,4-diaminopiperazine, 2, in the molecule, such as 3,6-diaminoacridine, bis (4-aminophenyl) phenylamine and the compound represented by the following formula (6) Diamine having nitrogen atoms other than the primary amino group and the primary amino group;

Figure pat00006
Figure pat00006

(식 중, R3은 피리딘, 피리미딘, 트리아진, 피페리딘 및 피페라진으로부터 선택되는 질소 원자를 포함하는 환 구조를 갖는 1가의 유기기를 나타내며, X1은 2가의 유기기를 나타냄)(Wherein R 3 represents a monovalent organic group having a ring structure containing a nitrogen atom selected from pyridine, pyrimidine, triazine, piperidine and piperazine, and X 1 represents a divalent organic group)

Figure pat00007
Figure pat00007

(식 중, R4는 피리딘, 피리미딘, 트리아진, 피페리딘 및 피페라진으로부터 선택되는 질소 원자를 포함하는 환 구조를 갖는 2가의 유기기를 나타내고, X2는 2가의 유기기를 나타내며, 복수개 존재하는 X2는 동일하거나 상이할 수 있음)(Wherein, R 4 represents a divalent organic group having a ring structure containing a nitrogen atom selected from pyridine, pyrimidine, triazine, piperidine, and piperazine, X 2 represents a divalent organic group, and a plurality of groups are present X 2 may be the same or different)

하기 화학식 8로 나타내지는 모노 치환 페닐렌디아민류; 하기 화학식 9로 나타내지는 디아미노오르가노실록산; Mono-substituted phenylenediamines represented by the following formula (8); Diaminoorganosiloxane represented by the following formula (9);

Figure pat00008
Figure pat00008

식 중, R5는 -O-, -COO-, -OCO-, -NHCO-, -CONH- 및 -CO-로부터 선택되는 2가의 유기기를 나타내고, R6은 스테로이드 골격, 트리플루오로메틸기 및 플루오로기에서 선택되는 기를 갖는 1가의 유기기 또는 탄소수 6 내지 30의 알킬기를 나타낸다.In the formula, R 5 represents a divalent organic group selected from -O-, -COO-, -OCO-, -NHCO-, -CONH-, and -CO-, and R 6 represents a steroid skeleton, a trifluoromethyl group and a fluorine group. Monovalent organic group or group having 6 to 30 carbon atoms having a group selected from a furnace group.

Figure pat00009
Figure pat00009

식 중, R7은 탄소수 1 내지 12의 탄화수소기를 나타내며, 복수개 존재하는 R7은 각각 동일하거나 상이할 수 있고, p는 1 내지 3의 정수이고, q는 1 내지 20의 정수이다.In formula, R <7> represents a C1-C12 hydrocarbon group, two or more R <7> may be same or different, p is an integer of 1-3 and q is an integer of 1-20.

하기 화학식 (1) 내지 (5)로 나타내지는 화합물 등을 들 수 있다. 이들 디아민 화합물은 단독으로 또는 2 종 이상 조합하여 사용할 수 있다. The compound etc. which are represented by following General formula (1)-(5) are mentioned. These diamine compounds can be used individually or in combination of 2 or more types.

Figure pat00010
Figure pat00010

식 중, y는 2 내지 12의 정수이고, z는 1 내지 5의 정수이다.In formula, y is an integer of 2-12 and z is an integer of 1-5.

이들 중, p-페닐렌디아민, 4,4'-디아미노디페닐메탄, 4,4'-디아미노디페닐술피드, 1,5-디아미노나프탈렌, 2,7-디아미노플루오렌, 4,4'-디아미노디페닐에테르, 2,2-비스[4-(4-아미노페녹시)페닐]프로판, 9,9-비스(4-아미노페닐)플루오렌, 2,2-비스[4-(4-아미노페녹시)페닐]헥사플루오로프로판, 2,2-비스(4-아미노페닐)헥사플루오로프로판, 4,4'-(p-페닐렌디이소프로필리덴)비스아닐린, 4,4'-(m-페닐렌디이소프로필리덴)비스아닐린, 1,4-시클로헥산디아민, 4,4'-메틸렌비스(시클로헥실아민), 1,4-비스(4-아미노페녹시)벤젠, 4,4'-비스(4-아미노페녹시)비페닐, 상기 화학식 (1) 내지 (5)로 나타내지는 화합물, 2,6-디아미노피리딘, 3,4-디아미노피리딘, 2,4-디아미노피리미딘, 3,6-디아미노아크리딘, 상기 화학식 6으로 나타내지는 화합물 중 하기 화학식 (6)으로 나타내지는 화합물, 상기 화학식 7로 나타내지는 화합물 중 하기 화학식 (7)로 나타내지는 화합물 및 상기 화학식 8로 나타내지는 화합물 중 하기 화학식 (8) 내지 (17)로 나타내지는 화합물, 및 상기 화학식 9로 나타내지는 화합물 중 1,3-비스(3-아미노프로필)헥사메틸디실록산이 바람직하다. Among them, p-phenylenediamine, 4,4'-diaminodiphenylmethane, 4,4'-diaminodiphenyl sulfide, 1,5-diaminonaphthalene, 2,7-diaminofluorene, 4 , 4'-diaminodiphenylether, 2,2-bis [4- (4-aminophenoxy) phenyl] propane, 9,9-bis (4-aminophenyl) fluorene, 2,2-bis [4 -(4-aminophenoxy) phenyl] hexafluoropropane, 2,2-bis (4-aminophenyl) hexafluoropropane, 4,4 '-(p-phenylenediisopropylidene) bisaniline, 4, 4 '-(m-phenylenediisopropylidene) bisaniline, 1,4-cyclohexanediamine, 4,4'-methylenebis (cyclohexylamine), 1,4-bis (4-aminophenoxy) benzene, 4,4'-bis (4-aminophenoxy) biphenyl, the compound represented by the formulas (1) to (5), 2,6-diaminopyridine, 3,4-diaminopyridine, 2,4- Diaminopyrimidine, 3,6-diaminoacridine, the compound represented by the following formula (6) among the compounds represented by the formula (6), the above Among the compounds represented by the following formula (7) of the compound represented by the formula (7) and the compound represented by the formula (8), the compound represented by the following formula (8) to (17), and the compound represented by the formula (9), Preference is given to 3-bis (3-aminopropyl) hexamethyldisiloxane.

Figure pat00011
Figure pat00011

<테트라카르복실산 이무수물> Tetracarboxylic dianhydride

특정 측쇄를 갖는 테트라카르복실산 이무수물로서 구체적으로는, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디플루오로-4-(4-n-프로필시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디플루오로-4-(4-n-부틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디플루오로-4-(4-n-펜틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디플루오로-4-(4-n-헥실시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디플루오로-4-(4-n-헥실시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디플루오로-4-(4-n-헵틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온; Specific examples of the tetracarboxylic dianhydride having a specific side chain include 1,3,3a, 4,5,9b-hexahydro-4- (2,3-difluoro-4- (4-n-propylcyclo). Hexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4 , 5,9b-hexahydro-4- (2,3-difluoro-4- (4-n-butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-fura Nil) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-difluoro-4- ( 4-n-pentylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1 , 3,3a, 4,5,9b-hexahydro-4- (2,3-difluoro-4- (4-n-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5 -Dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2,3- Difluoro-4- (4-n-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan -1,3-dione, 1,3,3a, 4,5,9b-hex Hydro-4- (2,3-difluoro-4- (4-n-heptylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [ 1,2-c] -furan-1,3-dione;

1,3,3a,4,5,9b-헥사히드로-4-(2,3-디시아노-4-(4-n-프로필시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디시아노-4-(4-n-부틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디시아노-4-(4-n-펜틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디시아노-4-(4-n-헥실시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디시아노-4-(4-n-헵틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온; 1,3,3a, 4,5,9b-hexahydro-4- (2,3-dicyano-4- (4-n-propylcyclohexyl) phenoxy) -5- (tetrahydro-2,5- Dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-dicy Ano-4- (4-n-butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1, 3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-dicyano-4- (4-n-pentylcyclohexyl) phenoxy) -5- (tetrahydro- 2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2 , 3-dicyano-4- (4-n-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] Furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-dicyano-4- (4-n-heptylcyclohexyl) phenoxy) -5 -(Tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione;

1,3,3a,4,5,9b-헥사히드로-4-(6-(4-n-프로필시클로헥실)-3-피리다지닐옥시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(6-(4-n-부틸시클로헥실)-3-피리다지닐옥시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(6-(4-n-펜틸시클로헥실)-3-피리다지닐옥시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(6-(4-n-헥실시클로헥실)-3-피리다지닐옥시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(6-(4-n-헵틸시클로헥실)-3-피리다지닐옥시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온; 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n-propylcyclohexyl) -3-pyridazinyloxy) -5- (tetrahydro-2,5-dioxo 3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n- Butylcyclohexyl) -3-pyridazinyloxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n-pentylcyclohexyl) -3-pyridazinyloxy) -5- (tetrahydro-2,5-dioxo 3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n- Hexylcyclohexyl) -3-pyridazinyloxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione , 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n-heptylcyclohexyl) -3-pyridazinyloxy) -5- (tetrahydro-2,5-di Oxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione;

1,3,3a,4,5,9b-헥사히드로-4-(2-플루오로-4-(4-n-프로필시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2-플루오로-4-(4-n-부틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2-플루오로-4-(4-n-펜틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2-플루오로-4-(4-n-헥실시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2-플루오로-4-(4-n-헵틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온; 1,3,3a, 4,5,9b-hexahydro-4- (2-fluoro-4- (4-n-propylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo 3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2-fluoro-4- (4-n-butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2-fluoro-4- (4-n-pentylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo 3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2-fluoro-4- (4-n-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione , 1,3,3a, 4,5,9b-hexahydro-4- (2-fluoro-4- (4-n-heptylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-di Oxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione;

1,3,3a,4,5,9b-헥사히드로-4-(3-플루오로-4-(4-n-프로필시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(3-플루오로-4-(4-n-부틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(3-플루오로-4-(4-n-펜틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(3-플루오로-4-(4-n-헥실시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(3-플루오로-4-(4-n-헵틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온; 1,3,3a, 4,5,9b-hexahydro-4- (3-fluoro-4- (4-n-propylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo -3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (3-fluoro-4- (4-n-butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (3-fluoro-4- (4-n-pentylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo -3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (3-fluoro-4- (4-n-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione , 1,3,3a, 4,5,9b-hexahydro-4- (3-fluoro-4- (4-n-heptylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-di Oxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione;

1,3,3a,4,5,9b-헥사히드로-4-(2-시아노-4-(4-n-프로필시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2-시아노-4-(4-n-부틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2-시아노-4-(4-n-펜틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2-시아노-4-(4-n-헥실시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2-시아노-4-(4-n-헵틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온; 1,3,3a, 4,5,9b-hexahydro-4- (2-cyano-4- (4-n-propylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo 3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2-cyano-4- (4-n-butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2-cyano-4- (4-n-pentylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo 3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2-cyano-4- (4-n-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione , 1,3,3a, 4,5,9b-hexahydro-4- (2-cyano-4- (4-n-heptylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-di Oxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione;

1,3,3a,4,5,9b-헥사히드로-4-(3-시아노-4-(4-n-프로필시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(3-시아노-4-(4-n-부틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(3-시아노-4-(4-n-펜틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(3-시아노-4-(4-n-헥실시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 및 1,3,3a,4,5,9b-헥사히드로-4-(3-시아노-4-(4-n-헵틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온을 들 수 있다. 1,3,3a, 4,5,9b-hexahydro-4- (3-cyano-4- (4-n-propylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo 3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (3-cyano-4- (4-n-butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (3-cyano-4- (4-n-pentylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo 3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (3-cyano-4- (4-n-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione And 1,3,3a, 4,5,9b-hexahydro-4- (3-cyano-4- (4-n-heptylcyclohexyl) phenoxy) -5- (tetrahydro-2,5- Dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione.

이들 중, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디플루오로-4-(4-n-프로필시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디플루오로-4-(4-n-부틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디플루오로-4-(4-n-펜틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디플루오로-4-(4-n-헥실시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디플루오로-4-(4-n-헥실시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디플루오로-4-(4-n-헵틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온; Among these, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-difluoro-4- (4-n-propylcyclohexyl) phenoxy) -5- (tetrahydro- 2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2 , 3-difluoro-4- (4-n-butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] Furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-difluoro-4- (4-n-pentylcyclohexyl) phenoxy)- 5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexa Hydro-4- (2,3-difluoro-4- (4-n-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-difluoro-4- (4-n-hex Silcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a , 4,5,9b-hexahydro-4- (2,3-difluoro-4- (4-n-heptylcyclohexyl) phenoxy) -5- (Tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione;

1,3,3a,4,5,9b-헥사히드로-4-(2,3-디시아노-4-(4-n-프로필시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디시아노-4-(4-n-부틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디시아노-4-(4-n-펜틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디시아노-4-(4-n-헥실시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(2,3-디시아노-4-(4-n-헵틸시클로헥실)페녹시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온; 1,3,3a, 4,5,9b-hexahydro-4- (2,3-dicyano-4- (4-n-propylcyclohexyl) phenoxy) -5- (tetrahydro-2,5- Dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-dicy Ano-4- (4-n-butylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1, 3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-dicyano-4- (4-n-pentylcyclohexyl) phenoxy) -5- (tetrahydro- 2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2 , 3-dicyano-4- (4-n-hexylcyclohexyl) phenoxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] Furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (2,3-dicyano-4- (4-n-heptylcyclohexyl) phenoxy) -5 -(Tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione;

1,3,3a,4,5,9b-헥사히드로-4-(6-(4-n-프로필시클로헥실)-3-피리다지닐옥시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(6-(4-n-부틸시클로헥실)-3-피리다지닐옥시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(6-(4-n-펜틸시클로헥실-3-피리다지닐옥시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-4-(6-(4-n-헥실시클로헥실)-3-피리다지닐옥시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 및 1,3,3a,4,5,9b-헥사히드로-4-(6-(4-n-헵틸시클로헥실)-3-피리다지닐옥시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온이 바람직하다. 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n-propylcyclohexyl) -3-pyridazinyloxy) -5- (tetrahydro-2,5-dioxo 3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n- Butylcyclohexyl) -3-pyridazinyloxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n-pentylcyclohexyl-3-pyridazinyloxy) -5- (tetrahydro-2,5-dioxo- 3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n-hex Silcyclohexyl) -3-pyridazinyloxy) -5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, And 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n-heptylcyclohexyl) -3-pyridazinyloxy) -5- (tetrahydro-2,5-di Preference is given to oxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione.

본 발명의 액정 배향제에 함유되는 중합체의 합성에 이용되는 그 밖의 테트라카르복실산 이무수물로는 예를 들면, 부탄테트라카르복실산 이무수물, 1,2,3,4-시클로부탄테트라카르복실산 이무수물, 1,2-디메틸-1,2,3,4-시클로부탄테트라카르복실산 이무수물, 1,3-디메틸-1,2,3,4-시클로부탄테트라카르복실산 이무수물, 1,3-디클로로-1,2,3,4-시클로부탄테트라카르복실산 이무수물, 1,2,3,4-테트라메틸-1,2,3,4-시클로부탄테트라카르복실산 이무수물, 1,2,3,4-시클로펜탄테트라카르복실산 이무수물, 1,2,4,5-시클로헥산테트라카르복실산 이무수물, 3,3',4,4'-디시클로헥실테트라카르복실산 이무수물, 2,3,5-트리카르복시시클로펜틸아세트산 이무수물, 3,5,6-트리카르복시노르보르난-2-아세트산 이무수물, 2,3,4,5-테트라히드로푸란테트라카르복실산 이무수물, 1,3,3a,4,5,9b-헥사히드로-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-5-메틸-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-5-에틸-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-7-메틸-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-7-에틸-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-8-메틸-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-8-에틸-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-5,8-디메틸-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온, 5-(2,5-디옥소테트라히드로푸라닐)-3-메틸-3-시클로헥센-1,2-디카르복실산 이무수물, 비시클로[2.2.2]-옥토-7-엔-2,3,5,6-테트라카르복실산 이무수물, 3-옥사비시클로[3.2.1]옥탄-2,4-디온-6-스피로-3'-(테트라히드로푸란-2',5'-디온), 하기 화학식 10 및 11로 나타내지는 화합물 등의 지방족 및 지환식 테트라카르복실산 이무수물;  As another tetracarboxylic dianhydride used for the synthesis | combination of the polymer contained in the liquid crystal aligning agent of this invention, butane tetracarboxylic dianhydride, 1,2,3,4-cyclobutane tetracarboxylic, for example. Acid dianhydrides, 1,2-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dichloro-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-tetramethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride , 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 3,3 ', 4,4'-dicyclohexyltetracarb Acid dianhydrides, 2,3,5-tricarboxycyclopentylacetic dianhydride, 3,5,6-tricarboxynorbornane-2-acetic dianhydride, 2,3,4,5-tetrahydrofuranthtetracar Acid dianhydrides, 1,3,3a, 4,5,9b-hexahydrate Rho-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b -Hexahydro-5-methyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a , 4,5,9b-hexahydro-5-ethyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione , 1,3,3a, 4,5,9b-hexahydro-7-methyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan -1,3-dione, 1,3,3a, 4,5,9b-hexahydro-7-ethyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1, 2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-8-methyl-5- (tetrahydro-2,5-dioxo-3-furanyl) Naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-8-ethyl-5- (tetrahydro-2,5-dioxo 3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro-5,8-dimethyl-5- (tetra Hydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] -furan-1,3-dione, 5- (2,5-dioxotetrahydrofu Yl) -3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride, bicyclo [2.2.2] -octo-7-ene-2,3,5,6-tetracarboxylic dianhydride Water, 3-oxabicyclo [3.2.1] octane-2,4-dione-6-spiro-3 '-(tetrahydrofuran-2', 5'-dione), a compound represented by the following formulas (10) and (11) Aliphatic and alicyclic tetracarboxylic dianhydrides such as;

Figure pat00012
Figure pat00012

Figure pat00013
Figure pat00013

(식 중, R8 및 R10은 방향환을 갖는 2가의 유기기를 나타내고, R9 및 R11은 수소 원자 또는 알킬기를 나타내며, 복수개 존재하는 R9 및 R11은 각각 동일하거나 상이할 수 있음)(Wherein R 8 and R 10 represent a divalent organic group having an aromatic ring, R 9 and R 11 represent a hydrogen atom or an alkyl group, and a plurality of R 9 and R 11 may be the same or different, respectively)

피로멜리트산 이무수물, 3,3',4,4'-벤조페논테트라카르복실산 이무수물, 3,3',4,4'-비페닐술폰테트라카르복실산 이무수물, 1,4,5,8-나프탈렌테트라카르복실산 이무수물, 2,3,6,7-나프탈렌테트라카르복실산 이무수물, 3,3',4,4'-비페닐에테르테트라카르복실산 이무수물, 3,3',4,4'-디메틸디페닐실란테트라카르복실산 이무수물, 3,3',4,4'-테트라페닐실란테트라카르복실산 이무수물, 1,2,3,4-푸란테트라카르복실산 이무수물, 4,4'-비스(3,4-디카르복시페녹시)디페닐술피드 이무수물, 4,4'-비스(3,4-디카르복시페녹시)디페닐술폰 이무수물, 4,4'-비스(3,4-디카르복시페녹시)디페닐프로판 이무수물, 3,3',4,4'-퍼플루오로이소프로필리덴디프탈산 이무수물, 3,3',4,4'-비페닐테트라카르복실산 이무수물, 비스(프탈산)페닐포스핀옥시드 이무수물, p-페닐렌-비스(트리페닐프탈산) 이무수물, m-페닐렌-비스(트리페닐프탈산) 이무수물, 비스(트리페닐프탈산)-4,4'-디페닐에테르 이무수물, 비스(트리페닐프탈산)-4,4'-디페닐메탄 이무수물, 에틸렌글리콜-비스(안히드로트리멜리테이트), 프로필렌글리콜-비스(안히드로트리멜리테이트), 1,4-부탄디올-비스(안히드로트리멜리테이트), 1,6-헥산디올-비스(안히드로트리멜리테이트), 1,8-옥탄디올-비스(안히드로트리멜리테이트), 2,2-비스(4-히드록시페닐)프로판-비스(안히드로트리멜리테이트), 하기 화학식 (18) 내지 (21)로 나타내지는 화합물 등의 방향족 테트라카르복실산 이무수물을 들 수 있다. 이들은 1종 단독으로 또는 2종 이상 조합하여 사용된다. Pyromellitic dianhydride, 3,3 ', 4,4'-benzophenonetetracarboxylic dianhydride, 3,3', 4,4'-biphenylsulfontetracarboxylic dianhydride, 1,4,5 , 8-naphthalenetetracarboxylic dianhydride, 2,3,6,7-naphthalenetetracarboxylic dianhydride, 3,3 ', 4,4'-biphenylethertetracarboxylic dianhydride, 3,3 ', 4,4'-dimethyldiphenylsilanetetracarboxylic dianhydride, 3,3', 4,4'-tetraphenylsilanetetracarboxylic dianhydride, 1,2,3,4-furantetracarboxylic Acid dianhydrides, 4,4'-bis (3,4-dicarboxyphenoxy) diphenylsulfide dianhydrides, 4,4'-bis (3,4-dicarboxyphenoxy) diphenylsulfone dianhydrides, 4 , 4'-bis (3,4-dicarboxyphenoxy) diphenylpropane dianhydride, 3,3 ', 4,4'-perfluoroisopropylidenediphthalic dianhydride, 3,3', 4,4 '-Biphenyltetracarboxylic dianhydride, bis (phthalic acid) phenylphosphineoxide dianhydride, p-phenylene-bis (triphenylphthalic acid) dianhydride, m-phenylene-bis (triphenylphthalic acid) dianhydride, bis (triphenylphthalic acid) -4,4'-diphenyl ether dianhydride, bis (triphenylphthalic acid) -4,4'-diphenylmethane dianhydride, Ethylene glycol bis (anhydrotrimelitate), propylene glycol bis (anhydro trimellitate), 1,4-butanediol-bis (anhydro trimellitate), 1,6-hexanediol-bis (anhydro Trimellitate), 1,8-octanediol-bis (anhydro trimellitate), 2,2-bis (4-hydroxyphenyl) propane-bis (anhydro trimellitate), formulas (18) to Aromatic tetracarboxylic dianhydrides, such as a compound represented by (21), are mentioned. These are used individually by 1 type or in combination of 2 or more types.

Figure pat00014
Figure pat00014

이들 중에서 부탄테트라카르복실산 이무수물, 1,2,3,4-시클로부탄테트라카르복실산 이무수물, 1,3-디메틸-1,2,3,4-시클로부탄테트라카르복실산 이무수물, 1,2,3,4-시클로펜탄테트라카르복실산 이무수물, 1,2,4,5-시클로헥산데트라카르복실산 이무수물, 2,3,5-트리카르복시시클로펜틸아세트산 이무수물, 5-(2,5-디옥소테트라히드로푸라닐)-3-메틸-3-시클로헥센-1,2-디카르복실산 이무수물, 1,3,3a,4,5,9b-헥사히드로-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-8-메틸-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-5,8-디메틸-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 비시클로[2.2.2]-옥토-7-엔-2,3,5,6-테트라카르복실산 이무수물, 3-옥사비시클로[3.2.1]옥탄-2,4-디온-6-스피로-3'-(테트라히드로푸란-2',5'-디온), 피로멜리트산 이무수물, 3,3',4,4'-벤조페논테트라카르복실산 이무수물, 3,3',4,4'-비페닐술폰테트라카르복실산 이무수물, 1,4,5,8-나프탈렌테트라카르복실산 이무수물, 상기 화학식 10으로 나타내지는 화합물 중 하기 화학식 (22) 내지 (24)로 나타내지는 화합물 및 상기 화학식 11로 나타내지는 화합물 중 하기 화학식 (25)로 나타내지는 화합물이 양호한 액정 배향성을 발현시킬 수 있다는 관점에서 바람직하고, 특히 바람직하게는 1,2,3,4-시클로부탄테트라카르복실산 이무수물, 1,3-디메틸-1,2,3,4-시클로부탄테트라카르복실산 이무수물, 1,2,4,5-시클로헥산테트라카르복실산 이무수물, 2,3,5-트리카르복시시클로펜틸아세트산 이무수물, 1,3,3a,4,5,9b-헥사히드로-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 1,3,3a,4,5,9b-헥사히드로-8-메틸-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]푸란-1,3-디온, 3-옥사비시클로[3.2.1]옥탄-2,4-디온-6-스피로-3'-(테트라히드로푸란-2',5'-디온), 피로멜리트산 이무수물 및 하기 화학식 (22)로 나타내지는 화합물을 들 수 있다.Among these, butanetetracarboxylic dianhydride, 1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,3,4-cyclopentanetetracarboxylic dianhydride, 1,2,4,5-cyclohexanedetracarboxylic dianhydride, 2,3,5-tricarboxycyclopentylacetic dianhydride, 5 -(2,5-dioxotetrahydrofuranyl) -3-methyl-3-cyclohexene-1,2-dicarboxylic dianhydride, 1,3,3a, 4,5,9b-hexahydro-5 -(Tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione, 1,3,3a, 4,5,9b-hexahydro- 8-methyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione, 1,3,3a, 4,5, 9b-hexahydro-5,8-dimethyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione, bicyclo [ 2.2.2] -octo-7-ene-2,3,5,6-tetracarboxylic dianhydride, 3-oxabicyclo [3.2.1] octane-2,4-dione-6-spiro -3 '-(tetrahydrofuran-2', 5'-dione), pyromellitic dianhydride, 3,3 ', 4,4'-benzophenonetetracarboxylic dianhydride, 3,3', 4, 4'-biphenylsulfontetracarboxylic dianhydride, 1,4,5,8-naphthalenetetracarboxylic dianhydride, the compound represented by the following formulas (22) to (24) Among the compounds represented by the above formula (11), the compound represented by the following formula (25) is preferable from the viewpoint of being able to express good liquid crystal alignment, and particularly preferably 1,2,3,4-cyclobutanetetracarboxylic acid Dianhydrides, 1,3-dimethyl-1,2,3,4-cyclobutanetetracarboxylic dianhydride, 1,2,4,5-cyclohexanetetracarboxylic dianhydride, 2,3,5-tri Carboxycyclopentylacetic dianhydride, 1,3,3a, 4,5,9b-hexahydro-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] Furan-1,3-dione, 1,3,3a, 4,5,9b- Sahydro-8-methyl-5- (tetrahydro-2,5-dioxo-3-furanyl) -naphtho [1,2-c] furan-1,3-dione, 3-oxabicyclo [3.2 .1] octane-2,4-dione-6-spiro-3 '-(tetrahydrofuran-2', 5'-dione), pyromellitic dianhydride and the compound represented by the following general formula (22) are mentioned. have.

Figure pat00015
Figure pat00015

<폴리아미드산의 합성>Synthesis of Polyamic Acid

폴리아미드산의 합성 반응에 제공되는 테트라카르복실산 이무수물과 디아민 화합물의 사용 비율은 디아민의 아미노기 1 당량에 대하여, 테트라카르복실산 이무수물의 산무수물기가 0.2 내지 2 당량이 되는 비율이 바람직하고, 더욱 바람직하게는 0.3 내지 1.2 당량이 되는 비율이다.The use ratio of the tetracarboxylic dianhydride and the diamine compound provided in the synthesis reaction of the polyamic acid is preferably a ratio such that the acid anhydride group of the tetracarboxylic dianhydride is 0.2 to 2 equivalents to 1 equivalent of the amino group of the diamine, More preferably, it is the ratio used as 0.3-1.2 equivalent.

폴리아미드산의 합성 반응은 유기 용매 중에서, 바람직하게는 -20 내지 150 ℃, 보다 바람직하게는 0 내지 100 ℃의 온도 조건하에서 행해진다. 여기에서 유기 용매로는 합성되는 폴리아미드산을 용해할 수 있는 것이면 특별히 제한되지 않으며, 예를 들면 1-메틸-2-피롤리돈, N,N-디메틸아세트아미드, N,N-디메틸포름아미드, 디메틸술폭시드, γ-부티롤락톤, 테트라메틸요소, 헥사메틸포스포르트리아미드 등의 비양성자계 극성 용매; m-크레졸, 크실레놀, 페놀, 할로겐화 페놀 등의 페놀계 용매를 들 수 있다. 또한, 유기 용매의 사용량(α)은 바람직하게는, 테트라카르복실산 이무수물 및 디아민 화합물의 총량(β)이 반응 용액의 총량(α+β)에 대하여 0.1 내지 30 중량%가 되도록 하는 양인 것이 바람직하다. Synthesis reaction of polyamic acid is performed in organic solvent, Preferably it is -20-150 degreeC, More preferably, it is carried out under the temperature conditions of 0-100 degreeC. The organic solvent is not particularly limited as long as it can dissolve the polyamic acid synthesized. For example, 1-methyl-2-pyrrolidone, N, N-dimethylacetamide, N, N-dimethylformamide Aprotic polar solvents such as dimethyl sulfoxide, γ-butyrolactone, tetramethylurea and hexamethylphosphortriamide; and phenol solvents such as m-cresol, xylenol, phenol, and halogenated phenol. The amount of the organic solvent (α) is preferably such that the total amount (β) of the tetracarboxylic dianhydride and the diamine compound is 0.1 to 30% by weight relative to the total amount (α + β) of the reaction solution. desirable.

또한, 상기 유기 용매에는 폴리아미드산의 빈용매인 알코올류, 케톤류, 에스테르류, 에테르류, 할로겐화 탄화수소류, 탄화수소류 등을, 생성되는 폴리아미드산이 석출되지 않는 범위에서 병용할 수 있다. 이러한 빈용매의 구체예로는 예를 들면 메틸알코올, 에틸알코올, 이소프로필알코올, 시클로헥산올, 4-히드록시-4-메틸-2-펜탄올, 에틸렌글리콜, 프로필렌글리콜, 1,4-부탄디올, 트리에틸렌글리콜, 에틸렌글리콜모노메틸에테르, 락트산에틸, 락트산부틸, 아세톤, 메틸에틸케톤, 메틸이소부틸케톤, 시클로헥사논, 아세트산메틸, 아세트산에틸, 아세트산부틸, 메틸메톡시프로피오네이트, 에틸에톡시프로피오네이트, 옥살산디에틸, 말론산디에틸, 디에틸에테르, 에틸렌글리콜메틸에테르, 에틸렌글리콜에틸에테르, 에틸렌글리콜-n-프로필에테르, 에틸렌글리콜-i-프로필에테르, 에틸렌글리콜-n-부틸에테르, 에틸렌글리콜디메틸에테르, 에틸렌글리콜에틸에테르아세테이트, 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜모노메틸에테르, 디에틸렌글리콜모노에틸에테르, 디에틸렌글리콜모노메틸에테르아세테이트, 디에틸렌글리콜모노에틸에테르아세테이트, 테트라히드로푸란, 디클로로메탄, 1,2-디클로로에탄, 1,4-디클로로부탄, 트리클로로에탄, 클로로벤젠, o-디클로로벤젠, 헥산, 헵탄, 옥탄, 벤젠, 톨루엔, 크실렌 등을 들 수 있다. In the organic solvent, alcohols, ketones, esters, ethers, halogenated hydrocarbons, hydrocarbons, and the like, which are poor solvents of polyamic acid, can be used together in a range in which the resulting polyamic acid is not precipitated. Specific examples of such poor solvents include methyl alcohol, ethyl alcohol, isopropyl alcohol, cyclohexanol, 4-hydroxy-4-methyl-2-pentanol, ethylene glycol, propylene glycol, 1,4-butanediol, for example. , Triethylene glycol, ethylene glycol monomethyl ether, ethyl lactate, butyl lactate, acetone, methyl ethyl ketone, methyl isobutyl ketone, cyclohexanone, methyl acetate, ethyl acetate, butyl acetate, methyl methoxy propionate, ethyl Oxypropionate, diethyl oxalate, diethyl malonate, diethyl ether, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol-n-propyl ether, ethylene glycol-i-propyl ether, ethylene glycol-n-butyl ether , Ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl Ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate, tetrahydrofuran, dichloromethane, 1,2-dichloroethane, 1,4-dichlorobutane, trichloroethane, Chlorobenzene, o-dichlorobenzene, hexane, heptane, octane, benzene, toluene, xylene and the like.

이상과 같이 하여, 폴리아미드산을 용해하여 이루어지는 반응 용액을 얻을 수 있다. 그리고 이 반응 용액을 대량의 빈용매 중에 부어 석출물을 얻고, 이 석출물을 감압하에 건조함으로써 폴리아미드산을 얻을 수 있다. 또한, 이 폴리아미드산을 다시 유기 용매에 용해시키고, 이어서 빈용매로 석출시키는 공정을 1회 또는 복수회 행함으로써 폴리아미드산을 정제할 수 있다. As described above, a reaction solution obtained by dissolving polyamic acid can be obtained. The reaction solution is poured into a large amount of poor solvent to obtain a precipitate, and the polyamic acid can be obtained by drying the precipitate under reduced pressure. In addition, the polyamic acid can be purified by dissolving the polyamic acid again in an organic solvent and then precipitating with a poor solvent once or plural times.

<이미드화 중합체의 합성> <Synthesis of imidized polymer>

본 발명의 액정 배향제를 구성하는 이미드화 중합체는 상기 폴리아미드산을 탈수 폐환함으로써 합성할 수 있다. 폴리아미드산의 탈수 폐환은 (Ⅰ) 폴리아미드산을 가열하는 방법에 의해, 또는 (Ⅱ) 폴리아미드산을 유기 용매에 용해하고, 이 용액 중에 탈수제 및 탈수 폐환 촉매를 첨가하고, 필요에 따라 가열하는 방법에 의해 행해진다. 또한, 본 발명에 사용되는 이미드화 중합체는 부분적으로 탈수 폐환된, 이미드화율(중합체 중의 전체 반복 단위에서 이미드환을 형성하여 이루어지는 반복 단위의 비율을 %로 나타낸 것)이 100 % 미만인 이미드화 중합체를 포함할 수도 있다. The imidation polymer which comprises the liquid crystal aligning agent of this invention can be synthesize | combined by dehydrating and ring-closing the said polyamic acid. Dehydration ring closure of polyamic acid is carried out by the method of heating (I) polyamic acid, or (II) polyamic acid is dissolved in an organic solvent, and a dehydrating agent and a dehydration ring closure catalyst are added to this solution, and it heats as needed. It is done by the method. In addition, the imidized polymer used in the present invention is an imidized polymer having a degree of imidization (expressed as a percentage of the repeating units formed by forming an imide ring in all the repeating units in the polymer in%) partially dehydrated and closed. It may also include.

상기 (Ⅰ)의 폴리아미드산을 가열하는 방법에서의 반응 온도는 바람직하게는 50 내지 200 ℃이고, 보다 바람직하게는 60 내지 170 ℃이다. 반응 온도가 50 ℃ 미만이면 탈수 폐환 반응이 충분히 진행되기 어렵고, 반응 온도가 200 ℃를 초과하면 얻어지는 이미드화 중합체(B)의 분자량이 저하되는 경우가 있다. Preferably the reaction temperature in the method of heating the polyamic acid of said (I) is 50-200 degreeC, More preferably, it is 60-170 degreeC. When reaction temperature is less than 50 degreeC, dehydration ring-closure reaction does not fully advance, and when reaction temperature exceeds 200 degreeC, the molecular weight of the imidation polymer (B) obtained may fall.

한편, 상기 (Ⅱ)의 폴리아미드산의 용액 중에 탈수제 및 탈수 폐환 촉매를 첨가하는 방법에 있어서, 탈수제로는 예를 들면 아세트산 무수물, 프로피온산 무수물, 트리플루오로아세트산 무수물 등의 산무수물을 사용할 수 있다. 탈수제의 사용량은 원하는 이미드화율에 따라 다르지만, 바람직하게는 폴리아미드산의 반복 단위 1 몰에 대하여 0.01 내지 20 몰이다. 또한, 탈수 폐환 촉매로는 예를 들면 피리딘, 콜리딘, 루티딘, 트리에틸아민 등의 3급 아민을 사용할 수 있다. 그러나 이들로 한정되는 것은 아니다. 탈수 폐환 촉매의 사용량은 사용하는 탈수제 1 몰에 대해 0.01 내지 10 몰로 하는 것이 바람직하다. 이미드화율은 상기의 탈수제, 탈수 폐환제가 많을수록 높일 수 있다. 또한, 탈수 폐환 반응에서 사용되는 유기 용매로는 폴리아미드산의 합성에 사용되는 것으로 예시된 유기 용매를 들 수 있다. 그리고 탈수 폐환 반응의 반응 온도는 바람직하게는 0 내지 180 ℃, 보다 바람직하게는 10 내지 150 ℃이다. 또한, 이와 같이 하여 얻어지는 반응 용액에 대하여 폴리아미드산의 정제 방법과 동일한 조작을 행함으로써 이미드화 중합체를 정제할 수 있다. On the other hand, in the method of adding a dehydrating agent and a dehydrating ring-closure catalyst to the solution of the polyamic acid of said (II), acid anhydrides, such as an acetic anhydride, a propionic anhydride, a trifluoroacetic anhydride, can be used as a dehydrating agent, for example. . The amount of dehydrating agent used depends on the desired imidation ratio, but is preferably 0.01 to 20 moles with respect to 1 mole of the repeating unit of the polyamic acid. As the dehydration ring closure catalyst, tertiary amines such as pyridine, collidine, lutidine and triethylamine can be used, for example. However, it is not limited to these. It is preferable that the usage-amount of a dehydration ring-closure catalyst shall be 0.01-10 mol with respect to 1 mol of dehydrating agents used. The imidation ratio can be raised so that there are many said dehydrating agents and dehydrating ring closure agents. As the organic solvent used in the dehydration ring closure reaction, an organic solvent exemplified as being used for the synthesis of polyamic acid may be mentioned. And the reaction temperature of dehydration ring-closure reaction becomes like this. Preferably it is 0-180 degreeC, More preferably, it is 10-150 degreeC. Moreover, the imidation polymer can be refine | purified by performing the same operation as the purification method of polyamic acid with respect to the reaction solution obtained in this way.

<말단 수식형 중합체><Terminal modified polymer>

폴리아미드산 및 이미드화 중합체는 분자량이 조절된 말단 수식형인 것일 수도 있다. 이 말단 수식형 중합체를 사용함으로써 본 발명의 효과를 떨어뜨리지 않고 액정 배향제의 도포 특성 등을 개선할 수 있다. 이러한 말단 수식형 중합체는 폴리아미드산을 합성할 때에 산 일무수물, 모노아민 화합물, 모노이소시아네이트 화합물 등을 반응계에 첨가함으로써 합성할 수 있다. 여기에서, 산 일무수물로는 예를 들면 말레산 무수물, 프탈산 무수물, 이타콘산 무수물, n-데실숙신산 무수물, n-도데실숙신산 무수물, n-테트라데실숙신산 무수물, n-헥사데실숙신산 무수물 등을 들 수 있다. 또한, 모노아민 화합물로는 예를 들면, 아닐린, 시클로헥실아민, n-부틸아민, n-펜틸아민, n-헥실아민, n-헵틸아민, n-옥틸아민, n-노닐아민, n-데실아민, n-운데실아민, n-도데실아민, n-트리데실아민, n-테트라데실아민, n-펜타데실아민, n-헥사데실아민, n-헵타데실아민, n-옥타데실아민, n-에이코실아민 등을 들 수 있다. 또한, 모노이소시아네이트 화합물로는 예를 들면 페닐이소시아네이트, 나프틸이소시아네이트 등을 들 수 있다. The polyamic acid and the imidized polymer may be terminally modified with molecular weight. By using this terminal modified polymer, the coating characteristic of a liquid crystal aligning agent, etc. can be improved, without degrading the effect of this invention. Such a terminally modified polymer can be synthesized by adding an acid anhydride, a monoamine compound, a monoisocyanate compound and the like to the reaction system when synthesizing the polyamic acid. Here, examples of the acid anhydride include maleic anhydride, phthalic anhydride, itaconic anhydride, n-decylsuccinic anhydride, n-dodecylsuccinic anhydride, n-tetradecylsuccinic anhydride, n-hexadecylsuccinic anhydride, and the like. Can be mentioned. As the monoamine compound, for example, aniline, cyclohexylamine, n-butylamine, n-pentylamine, n-hexylamine, n-heptylamine, n-octylamine, n-nonylamine, n-decyl Amines, n-undecylamine, n-dodecylamine, n-tridecylamine, n-tetradecylamine, n-pentadecylamine, n-hexadecylamine, n-heptadecylamine, n-octadecylamine, n-eicosylamine etc. are mentioned. Moreover, as a monoisocyanate compound, phenyl isocyanate, naphthyl isocyanate, etc. are mentioned, for example.

<액정 배향제><Liquid crystal aligning agent>

본 발명의 액정 배향제는 특정 측쇄를 갖는 중합체, 통상은 폴리아미드산 및(또는) 이미드화 중합체가 유기 용매 중에 용해, 함유되어 구성된다. The liquid crystal aligning agent of this invention is comprised by melt | dissolving and containing the polymer which has a specific side chain, usually a polyamic acid and / or an imidation polymer in an organic solvent.

본 발명의 액정 배향제를 제조할 때의 온도는 바람직하게는 0 ℃ 내지 200 ℃, 보다 바람직하게는 20 ℃ 내지 60 ℃이다.The temperature at the time of manufacturing the liquid crystal aligning agent of this invention becomes like this. Preferably it is 0 degreeC-200 degreeC, More preferably, it is 20 degreeC-60 degreeC.

본 발명의 액정 배향제를 구성하는 유기 용매로는 폴리아미드산의 합성 반응에 사용되는 것으로 예시된 용매를 들 수 있다. 또한, 폴리아미드산의 합성 반응시에 병용할 수 있는 것으로 예시된 빈용매도 적절하게 선택하여 병용할 수 있다. 이들 중에서도 1-메틸-2-피롤리돈과 표면 장력이 32 dyn/cm 이하인 용제를 사용하는 것이 바람직하다. 표면 장력이 32 dyn/cm 이하인 용제로는 예를 들면, 4-히드록시-4-메틸-2-펜탄올, 에틸렌글리콜모노메틸에테르, 락트산부틸, 아세트산부틸, 메틸메톡시프로피오네이트, 에틸에톡시프로피오네이트, 에틸렌글리콜메틸에테르, 에틸렌글리콜에틸에테르, 에틸렌글리콜-n-프로필에테르, 에틸렌글리콜-i-프로필에테르, 에틸렌글리콜-n-부틸에테르, 에틸렌글리콜디메틸에테르, 에틸렌글리콜에틸에테르아세테이트, 디에틸렌글리콜디메틸에테르, 디에틸렌글리콜디에틸에테르, 디에틸렌글리콜모노메틸에테르, 디에틸렌글리콜모노에틸에테르, 디에틸렌글리콜모노메틸에테르아세테이트, 디에틸렌글리콜모노에틸에테르아세테이트 등을 들 수 있다. As an organic solvent which comprises the liquid crystal aligning agent of this invention, the solvent illustrated to be used for the synthesis reaction of polyamic acid is mentioned. Moreover, the poor solvent illustrated as being usable together at the time of the synthesis reaction of polyamic acid can also be selected suitably, and can be used together. Among these, it is preferable to use 1-methyl-2-pyrrolidone and the solvent whose surface tension is 32 dyn / cm or less. Examples of the solvent having a surface tension of 32 dyn / cm or less include 4-hydroxy-4-methyl-2-pentanol, ethylene glycol monomethyl ether, butyl lactate, butyl acetate, methylmethoxypropionate, and ethyl. Oxypropionate, ethylene glycol methyl ether, ethylene glycol ethyl ether, ethylene glycol-n-propyl ether, ethylene glycol-i-propyl ether, ethylene glycol-n-butyl ether, ethylene glycol dimethyl ether, ethylene glycol ethyl ether acetate, Diethylene glycol dimethyl ether, diethylene glycol diethyl ether, diethylene glycol monomethyl ether, diethylene glycol monoethyl ether, diethylene glycol monomethyl ether acetate, diethylene glycol monoethyl ether acetate and the like.

1-메틸-2-피롤리돈과 표면 장력이 32 dyn/cm 이하인 용제의 비율은 1-메틸-2-피롤리돈이 20 내지 60 중량%, 표면 장력이 32 dyn/cm 이하인 용제가 80 내지 40 중량%인 것이 바람직하다. 이 비율의 범위를 벗어나면 중합체의 석출이 발생하거나 레벨링이 불충분하거나 하기 때문에 충분한 인쇄성을 얻을 수 없다. The ratio of 1-methyl-2-pyrrolidone and a solvent having a surface tension of 32 dyn / cm or less is 20 to 60 wt% of 1-methyl-2-pyrrolidone and a solvent having a surface tension of 32 dyn / cm or less is 80 to It is preferable that it is 40 weight%. Outside the range of this ratio, sufficient printability cannot be obtained because precipitation of the polymer occurs or leveling is insufficient.

본 발명의 액정 배향제에 있어서 고형분 농도는 점성, 휘발성 등을 고려하여 선택되지만, 바람직하게는 1 내지 10 중량%의 범위이다. 즉, 본 발명의 액정 배향제는 기판 표면에 도포되어 액정 배향막이 되는 도막이 형성되지만, 고형분 농도가 1 중량% 미만인 경우에는 이 도막의 막 두께가 지나치게 얇아지므로 양호한 액정 배향막을 얻을 수 없고, 고형분 농도가 10 중량%를 초과하는 경우에는 도막의 막 두께가 지나치게 두꺼워지므로 양호한 액정 배향막을 얻을 수 없고, 또한 액정 배향제의 점성이 증대되어 도포 특성이 떨어진다. In the liquid crystal aligning agent of this invention, although solid content concentration is selected in consideration of viscosity, volatility, etc., Preferably it is the range of 1 to 10 weight%. That is, although the liquid crystal aligning agent of this invention is apply | coated to the surface of a board | substrate, and the coating film used as a liquid crystal aligning film is formed, when solid content concentration is less than 1 weight%, since the film thickness of this coating film becomes too thin, a favorable liquid crystal aligning film cannot be obtained and solid content concentration is carried out. When the content exceeds 10% by weight, the film thickness of the coating film becomes too thick, so that a good liquid crystal aligning film cannot be obtained, and the viscosity of the liquid crystal aligning agent is increased, resulting in poor coating properties.

본 발명의 액정 배향제에는 목적으로 하는 물성을 손상하지 않는 범위 내에서 기판 표면에 대한 접착성을 향상시키는 관점에서, 관능성 실란 함유 화합물, 에폭시 화합물이 함유되어 있을 수도 있다. 이러한 관능성 실란 함유 화합물로는 예를 들면, 3-아미노프로필트리메톡시실란, 3-아미노프로필트리에톡시실란, 2-아미노프로필트리메톡시실란, 2-아미노프로필트리에톡시실란, N-(2-아미노에틸)-3-아미노프로필트리메톡시실란, N-(2-아미노에틸)-3-아미노프로필메틸디메톡시실란, 3-우레이도프로필트리메톡시실란, 3-우레이도프로필트리에톡시실란, N-에톡시카르보닐-3-아미노프로필트리메톡시실란, N-에톡시카르보닐-3-아미노프로필트리에톡시실란, N-트리에톡시실릴프로필트리에틸렌트리아민, N-트리메톡시실릴프로필트리에틸렌트리아민, 10-트리메톡시실릴-1,4,7-트리아자데칸, 10-트리에톡시실릴-1,4,7-트리아자데칸, 9-트리메톡시실릴-3,6-디아자노닐아세테이트, 9-트리에톡시실릴-3,6-디아자노닐아세테이트, N-벤질-3-아미노프로필트리메톡시실란, N-벤질-3-아미노프로필트리에톡시실란, N-페닐-3-아미노프로필트리메톡시실란, N-페닐-3-아미노프로필트리에톡시실란, N-비스(옥시에틸렌)-3-아미노프로필트리메톡시실란, N-비스(옥시에틸렌)-3-아미노프로필트리에톡시실란 등을 들 수 있다. 이러한 에폭시기 함유 화합물로는, 예를 들면 에틸렌글리콜디글리시딜에테르, 폴리에틸렌글리콜디글리시딜에테르, 프로필렌글리콜디글리시딜에테르, 트리프로필렌글리콜디글리시딜에테르, 폴리프로필렌글리콜디글리시딜에테르, 네오펜틸글리콜디글리시딜에테르, 1,6-헥산디올디글리시딜에테르, 글리세린디글리시딜에테르, 2,2-디브로모네오펜틸글리콜디글리시딜에테르, 1,3,5,6-테트라글리시딜-2,4-헥산디올, N,N,N',N'-테트라글리시딜-m-크실렌디아민, 1,3-비스(N,N-디글리시딜아미노메틸)시클로헥산, N,N,N',N'-테트라글리시딜-4,4'-디아미노디페닐메탄, 3-(N-알릴-N-글리시딜)아미노프로필트리메톡시실란, 3-(N,N-디글리시딜)아미노프로필트리메톡시실란 등을 들 수 있다. The functional silane containing compound and the epoxy compound may be contained in the liquid crystal aligning agent of this invention from a viewpoint of improving the adhesiveness to the board | substrate surface in the range which does not impair the target physical property. Examples of such functional silane-containing compounds include 3-aminopropyltrimethoxysilane, 3-aminopropyltriethoxysilane, 2-aminopropyltrimethoxysilane, 2-aminopropyltriethoxysilane, and N-. (2-aminoethyl) -3-aminopropyltrimethoxysilane, N- (2-aminoethyl) -3-aminopropylmethyldimethoxysilane, 3-ureidopropyltrimethoxysilane, 3-ureidopropyltree Ethoxysilane, N-ethoxycarbonyl-3-aminopropyltrimethoxysilane, N-ethoxycarbonyl-3-aminopropyltriethoxysilane, N-triethoxysilylpropyltriethylenetriamine, N- Trimethoxysilylpropyltriethylenetriamine, 10-trimethoxysilyl-1,4,7-triazadecan, 10-triethoxysilyl-1,4,7-triazadecan, 9-trimethoxysilyl -3,6-diazanyl acetate, 9-triethoxysilyl-3,6-diazanyl acetate, N-benzyl-3-aminopropyltrimethoxysilane, N-benzyl -3-aminopropyltriethoxysilane, N-phenyl-3-aminopropyltrimethoxysilane, N-phenyl-3-aminopropyltriethoxysilane, N-bis (oxyethylene) -3-aminopropyltrimeth Oxysilane, N-bis (oxyethylene) -3-aminopropyltriethoxysilane, etc. are mentioned. Examples of such epoxy group-containing compounds include ethylene glycol diglycidyl ether, polyethylene glycol diglycidyl ether, propylene glycol diglycidyl ether, tripropylene glycol diglycidyl ether, and polypropylene glycol diglycidyl. Ether, neopentyl glycol diglycidyl ether, 1,6-hexanediol diglycidyl ether, glycerin diglycidyl ether, 2,2-dibromoneopentyl glycol diglycidyl ether, 1,3, 5,6-tetraglycidyl-2,4-hexanediol, N, N, N ', N'-tetraglycidyl-m-xylenediamine, 1,3-bis (N, N-diglycidyl Aminomethyl) cyclohexane, N, N, N ', N'-tetraglycidyl-4,4'-diaminodiphenylmethane, 3- (N-allyl-N-glycidyl) aminopropyltrimethoxy Silane, 3- (N, N- diglycidyl) aminopropyltrimethoxysilane, etc. are mentioned.

<액정 표시 소자> <Liquid crystal display element>

본 발명의 액정 배향제를 사용하여 얻어지는 액정 표시 소자는, 예를 들면 다음 방법에 의해서 제조할 수 있다.The liquid crystal display element obtained using the liquid crystal aligning agent of this invention can be manufactured, for example by the following method.

(1) 패턴화된 투명 도전막이 설치되어 있는 기판의 한 면에 본 발명의 액정 배향제를 롤 코터법, 스피너법, 인쇄법 등의 방법에 의해 도포하고, 계속해서 도포면을 가열함으로써 도막을 형성한다. 여기서, 기판으로는 예를 들면, 플로트(float) 유리, 소다 유리 등의 유리; 폴리에틸렌테레프탈레이트, 폴리부틸렌테레프탈레이트, 폴리에테르술폰, 폴리카르보네이트 등의 플라스틱으로 이루어지는 투명 기판을 사용할 수 있다. 기판의 한 면에 설치되는 투명 도전막으로는 산화주석(SnO2)을 포함하는 NESA 막(미국 PPG사 등록상표), 산화인듐-산화주석(In2O3-SnO2)을 포함하는 ITO 막 등을 사용할 수 있고, 이러한 투명 도전막의 패턴화에는 포토ㆍ에칭법이나 미리 마스크를 사용하는 방법이 이용된다. 액정 배향제를 도포할 때는 기판 표면 및 투명 도전막과 도막과의 접착성을 더욱 양호하게 하기 위해서, 기판의 상기 표면에 관능성 실란 함유 화합물, 관능성 티탄 함유 화합물 등을 미리 도포할 수도 있다. 액정 배향제 도포 후의 가열 온도는 바람직하게는 80 내지 300 ℃이고, 보다 바람직하게는 120 내지 250 ℃이다. 또한, 폴리아미드산을 함유하는 본 발명의 액정 배향제는 도포 후에 유기 용매를 제거함으로써 배향막이 되는 도막을 형성하지만, 더욱 가열함으로써 탈수 폐환을 진행시켜 보다 이미드화된 도막을 형성할 수도 있다. 형성되는 도막의 막 두께는 바람직하게는 0.001 내지 1 ㎛이고, 보다 바람직하게는 0.005 내지 0.5 ㎛이다. (1) The liquid crystal aligning agent of this invention is apply | coated to the one surface of the board | substrate with which the patterned transparent conductive film is provided by methods, such as a roll coater method, a spinner method, and a printing method, and then a coating film is formed by heating a coating surface. do. Here, as a board | substrate, For example, glass, such as float glass and a soda glass; A transparent substrate made of plastic such as polyethylene terephthalate, polybutylene terephthalate, polyether sulfone and polycarbonate can be used. As a transparent conductive film provided on one side of the substrate, an NESA film containing tin oxide (SnO 2 ) (registered trademark of PPG Co., Ltd.) and an ITO film containing indium tin oxide (In 2 O 3 -SnO 2 ) Etc. can be used, and a photo-etching method or a method of using a mask in advance is used for patterning such a transparent conductive film. When apply | coating a liquid crystal aligning agent, in order to make adhesiveness of a board | substrate surface, a transparent conductive film, and a coating film more favorable, you may apply | coat a functional silane containing compound, a functional titanium containing compound, etc. previously on the said surface of a board | substrate. The heating temperature after liquid crystal aligning agent application becomes like this. Preferably it is 80-300 degreeC, More preferably, it is 120-250 degreeC. In addition, although the liquid crystal aligning agent of this invention containing a polyamic acid forms the coating film which becomes an oriented film by removing an organic solvent after application | coating, further heating can advance dehydration ring closure, and can also form more imidized coating film. The film thickness of the coating film formed becomes like this. Preferably it is 0.001-1 micrometer, More preferably, it is 0.005-0.5 micrometer.

(2) 형성된 도막면을 필요에 따라, 예를 들면 나일론, 레이온, 면화 등의 섬유로 이루어지는 천을 감은 롤로 일정한 방향으로 문지르는 러빙 처리를 행한다. 이에 따라, 도막상의 액정 분자에 프리틸트각을 부여할 수 있고, 전압 인가시에 액정 분자가 무너지는 방향을 제어할 수 있게 된다. 또한, 경우에 따라서는 러빙법에 의하지 않고 편광 또는 무편광의 자외선, 또는 이온빔 등을 도막에 조사함으로써 프리틸트각을 부여할 수도 있다. (2) The rubbing process of rubbing in a fixed direction is performed with the roll which rolled the cloth which consists of fibers, such as nylon, rayon, and cotton, for example as needed. Thereby, the pretilt angle can be provided to the liquid crystal molecules on the coating film, and the direction in which the liquid crystal molecules collapse upon application of voltage can be controlled. In some cases, the pretilt angle may be provided by irradiating the coating film with ultraviolet light or an ion beam of polarized light or polarized light without using the rubbing method.

또한, 본 발명의 수직 배향형 액정 표시 소자에 있어서, 전압 인가시에 액정 분자가 무너지는 방향을 횡전계, 기판상의 돌기 등에 의해 제어하는 경우에는 상기의 러빙 등의 처리를 반드시 행할 필요없이 상기 도막을 그대로 액정 배향막으로 사용할 수도 있다. Moreover, in the vertically-aligned liquid crystal display element of this invention, when controlling the direction in which a liquid crystal molecule collapses at the time of voltage application by a transverse electric field, the processus | protrusion on a board | substrate, etc., the said coating film is not necessarily performed. It can also be used as a liquid crystal aligning film as it is.

(3) 상기한 바와 같이 하여 액정 배향막이 형성된 기판을 2장 제작하고, 각각의 액정 배향막에서 러빙 방향(또는, 전압 인가시의 액정 분자의 무너진 방향)이 역평행하게 되도록 2장의 기판을 간극(셀갭)을 통해 대향 배치하고, 2장의 기판 주변부를 밀봉제를 사용하여 접합시키고, 기판 표면 및 밀봉제에 의해 구획된 셀갭 내에 액정을 주입 충전하고, 주입 구멍을 봉지하여 액정 셀을 구성한다. 그리고 액정 셀의 외표면, 즉 액정 셀을 구성하는 각각의 기판의 다른 면측에, 편광판을, 그의 편광 방향이 해당 기판의 한 면에 형성된 액정 배향막의 러빙 방향(또는, 전압 인가시의 액정 분자의 무너진 방향)과 45° 각도를 이루도록 접합시킴으로써 액정 표시 소자를 얻을 수 있다. (3) Two board | substrates with a liquid crystal aligning film were produced as mentioned above, and two board | substrates were separated so that the rubbing direction (or the collapsed direction of the liquid crystal molecule at the time of voltage application) may become antiparallel in each liquid crystal aligning film ( The cell gaps are disposed to face each other, two peripheral portions of the substrate are bonded together with a sealant, a liquid crystal is injected and filled into the cell surface partitioned by the substrate surface and the sealant, and the injection hole is sealed to form a liquid crystal cell. On the outer surface of the liquid crystal cell, that is, the other surface side of each substrate constituting the liquid crystal cell, a polarizing plate is placed in a rubbing direction (or liquid crystal molecules at the time of voltage application) of the liquid crystal alignment film whose polarization direction is formed on one side of the substrate. The liquid crystal display element can be obtained by bonding so that it may form an angle of 45 degrees with the collapsed direction).

여기에서, 밀봉제로는 예를 들면 경화제 및 스페이서로서의 산화 알루미늄 구(球)를 함유하는 에폭시 수지 등을 사용할 수 있다. Here, as the sealant, for example, an epoxy resin or the like containing an aluminum oxide sphere as a curing agent and a spacer can be used.

액정으로는 네마틱형 액정 및 스메틱형 액정을 들 수 있고, 그 중에서도 네마틱형 액정이 바람직하며, 예를 들면 시프베이스계 액정, 아족시계 액정, 비페닐계 액정, 페닐시클로헥산계 액정, 에스테르계 액정, 테르페닐계 액정, 비페닐시클로헥산계 액정, 피리미딘계 액정, 디옥산계 액정, 비시클로옥탄계 액정, 큐반계 액정 등을 사용할 수 있다. 또한, 이러한 액정에 예를 들면 콜레스틸 클로라이드, 콜레스테릴 노나에이트, 콜레스테릴 카르보네이트 등의 콜레스테릭형 액정이나, 상품명 "C-15", "CB-15"(메르크사 제조)로 판매되는 것과 같은 키랄제 등을 첨가하여 사용할 수도 있다. 또한, p-디실록시벤질리덴-p-아미노-2-메틸부틸 신나메이트 등의 강유전성 액정도 사용할 수 있다. Examples of the liquid crystal include nematic liquid crystals and smectic liquid crystals, and among them, nematic liquid crystals are preferable, and for example, a sieve base liquid crystal, a subfamily clock liquid crystal, a biphenyl liquid crystal, a phenylcyclohexane liquid crystal and an ester type A liquid crystal, a terphenyl type liquid crystal, a biphenyl cyclohexane type liquid crystal, a pyrimidine type liquid crystal, a dioxane type liquid crystal, a bicyclooctane type liquid crystal, a cuban type liquid crystal, etc. can be used. In addition, such liquid crystals are, for example, cholesteric liquid crystals such as cholesteryl chloride, cholesteryl nonaate, cholesteryl carbonate, and trade names "C-15" and "CB-15" (manufactured by Merck Co., Ltd.). The chiral agent etc. which are sold can also be added and used. Ferroelectric liquid crystals such as p-disiloxybenzylidene-p-amino-2-methylbutyl cinnamate can also be used.

또한, 액정 셀의 외표면에 접합되는 편광판으로는, 폴리비닐알코올을 연신 배향시키면서 요오드를 흡수시킨 H막이라고 불리우는 편광막을 아세트산셀룰로오스 보호막 사이에 끼운 편광판 또는 H막 그 자체로 이루어지는 편광판을 들 수 있다. Moreover, as a polarizing plate bonded to the outer surface of a liquid crystal cell, the polarizing plate which consists of a polarizing plate called H film which absorbed iodine, and extended | stretched polyvinyl alcohol between the cellulose acetate protective film, or the polarizing plate which consists of H film itself is mentioned. .

<실시예><Examples>

이하, 본 발명을 실시예에 의해 더욱 구체적으로 설명하지만, 본 발명이 이들 실시예로 제한되는 것은 아니다. 또한, 이하의 실시예 및 비교예에서의 액정 표시 소자의 평가 방법은 이하와 같다. Hereinafter, although an Example demonstrates this invention further more concretely, this invention is not restrict | limited to these Examples. In addition, the evaluation method of the liquid crystal display element in the following Example and a comparative example is as follows.

〔액정 표시 소자의 프리틸트각〕[Pretilt Angle of Liquid Crystal Display Element]

문헌(T.J. Scheffer, et. al., J. Appl. Phys., vol. 19, 2013(1980))에 기재된 방법에 준거하여, He-Ne 레이저광을 사용하는 결정 회전법에 의해 측정하였다(여기서의 프리틸트각은 액정 분자의 배향 방향이 기판면에서 기울어져 있는 각도로 정의됨).Based on the method described in TJ Scheffer, et. Al., J. Appl. Phys., Vol. 19, 2013 (1980), it was measured by a crystal rotation method using a He-Ne laser beam (here Pretilt angle is defined as the angle at which the orientation direction of the liquid crystal molecules is tilted at the substrate surface).

합성예 1Synthesis Example 1

폴리아미드산의Of polyamic acid 중합 polymerization

2,3,5-트리카르복시시클로펜틸아세트산 이무수물 0.1 몰(22.4 g)과 1-(2,3-디플루오로-4-(4-n-헥실시클로헥실)페녹시)-2,4-디아미노벤젠 0.1 몰(40.3 g)을 N-메틸-2-피롤리돈 300 g에 용해시켜 60 ℃에서 6 시간 반응시켰다. 계속해서, 반응 혼합물을 매우 과잉의 메탄올에 부어 반응 생성물을 침전시켰다. 그 후 메탄올로 세정하고, 감압하에 40 ℃에서 15 시간 건조시켜 폴리아미드산(이하, "중합체 1a"라 함) 62 g을 얻었다. 0.1 mole (22.4 g) of 2,3,5-tricarboxycyclopentylacetic dianhydride and 1- (2,3-difluoro-4- (4-n-hexylcyclohexyl) phenoxy) -2,4 0.1 mol (40.3 g) of diaminobenzene was dissolved in 300 g of N-methyl-2-pyrrolidone and reacted at 60 ° C for 6 hours. The reaction mixture was then poured into very excess methanol to precipitate the reaction product. Then, the mixture was washed with methanol and dried at 40 ° C. under reduced pressure for 15 hours to obtain 62 g of polyamic acid (hereinafter referred to as “polymer 1a”).

이미드화Imidization 반응 reaction

31.2 g의 중합체 1a에 N-메틸-2-피롤리돈 380 g, 피리딘 7.9 g 및 아세트산 무수물 10.2 g을 첨가하여 120 ℃에서 4 시간 이미드화 반응을 행하였다. 계속해서, 반응 혼합액을 매우 과잉의 메탄올에 부어 반응 생성물을 침전시켰다. 그 후 메탄올로 세정하고, 감압하에서 15 시간 건조시켜 이미드화 중합체(이하, "중합체 1b"라 함) 29 g을 얻었다. 380 g of N-methyl-2-pyrrolidone, 7.9 g of pyridine, and 10.2 g of acetic anhydride were added to 31.2 g of polymer 1a, and an imidization reaction was performed at 120 ° C for 4 hours. Subsequently, the reaction mixture was poured into an excessive amount of methanol to precipitate the reaction product. Thereafter, the mixture was washed with methanol and dried under reduced pressure for 15 hours to obtain 29 g of an imidized polymer (hereinafter referred to as "polymer 1b").

합성예 2Synthesis Example 2

폴리아미드산의Of polyamic acid 중합 polymerization

1-(2,3-디플루오로-4-(4-n-헥실시클로헥실)페녹시)-2,4-디아미노벤젠 0.1 몰(40.1 g) 대신에 (2,3-디시아노-4-(4-n-펜틸시클로헥실)페닐)-3,5-디아미노벤조에이트 0.1 몰(43.1 g)을 사용한 것 이외에는 합성예 1과 동일하게 하여 폴리아미드산(이하, "중합체 2a"라 함) 64 g을 얻었다. 1- (2,3-difluoro-4- (4-n-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene instead of 0.1 mole (40.1 g) of (2,3-dicyano- Polyamic acid (hereinafter referred to as "polymer 2a") in the same manner as in Synthesis Example 1 except that 0.1 mol (43.1 g) of 4- (4-n-pentylcyclohexyl) phenyl) -3,5-diaminobenzoate was used. 64 g was obtained.

이미드화Imidization 반응 reaction

31.2 g의 중합체 1a 대신에 32.8 g의 중합체 2a를 사용한 것 이외에는 합성예 1과 동일하게 하여 이미드화 중합체(이하, "중합체 2b"라 함) 30 g을 얻었다. 30 g of an imidized polymer (hereinafter, referred to as "polymer 2b") was obtained in the same manner as in Synthesis example 1 except that 32.8 g of polymer 2a was used instead of 31.2 g of polymer 1a.

합성예 3Synthesis Example 3

폴리아미드산의Of polyamic acid 중합 polymerization

1-(2,3-디플루오로-4-(4-n-헥실시클로헥실)페녹시)-2,4-디아미노벤젠 0.1 몰(40.3 g) 대신에 1-(6-(4-n-헥실시클로헥실)-3-피리다지닐옥시)-2,4-디아미노벤젠 0.1 몰(36.8 g)을 사용한 것 이외에는 합성예 1과 동일하게 하여 폴리아미드산(이하, "중합체 3a"라 함) 57 g을 얻었다. 1- (2- (6- (4-) instead of 0.1 mol (40.3 g) of 1, (2,3-difluoro-4- (4-n-hexylcyclohexyl) phenoxy) -2,4-diaminobenzene Polyamic acid (hereinafter referred to as "polymer 3a") in the same manner as in Synthesis example 1 except that 0.1 mol (36.8 g) of n-hexylcyclohexyl) -3-pyridazinyloxy) -2,4-diaminobenzene was used. 57 g was obtained.

이미드화Imidization 반응 reaction

31.2 g의 중합체 1a 대신에 29.6 g의 중합체 3a를 사용한 것 이외에는 합성예 1과 동일하게 하여 이미드화 중합체(이하, "중합체 3b"라 함) 26 g을 얻었다. 26 g of imidized polymer (hereinafter, referred to as "polymer 3b") was obtained in the same manner as in Synthesis example 1 except that 29.6 g of polymer 3a was used instead of 31.2 g of polymer 1a.

합성예 4Synthesis Example 4

폴리아미드산의Of polyamic acid 중합 polymerization

1,3,3a,4,5,9b-헥사히드로-4-(6-(4-n-펜틸시클로헥실)-3-피리다지닐옥시)-5-(테트라히드로-2,5-디옥소-3-푸라닐)-나프토[1,2-c]-푸란-1,3-디온 0.1 몰(54.6 g)과 p-페닐렌디아민 0.1 몰(10.8 g)을 N-메틸-2-피롤리돈 300 g에 용해시켜 60 ℃에서 6 시간 반응시켰다. 계속해서, 반응 혼합물을 매우 과잉의 메탄올에 부어 반응 생성물을 침전시켰다. 그 후 메탄올로 세정하고 감압하에 40 ℃에서 15 시간 건조시켜 폴리아미드산(이하, "중합체 4a"라 함) 64 g을 얻었다. 1,3,3a, 4,5,9b-hexahydro-4- (6- (4-n-pentylcyclohexyl) -3-pyridazinyloxy) -5- (tetrahydro-2,5-dioxo 0.1 mol (54.6 g) of -3-furanyl) -naphtho [1,2-c] -furan-1,3-dione and 0.1 mol (10.8 g) of p-phenylenediamine were N-methyl-2-pi It melt | dissolved in 300 g of rollidone, and made it react at 60 degreeC for 6 hours. The reaction mixture was then poured into very excess methanol to precipitate the reaction product. Thereafter, the mixture was washed with methanol and dried at 40 DEG C for 15 hours under reduced pressure to obtain 64 g of polyamic acid (hereinafter referred to as "polymer 4a").

이미드화Imidization 반응 reaction

31.2 g의 중합체 1a 대신에 32.7 g의 중합체 4a를 사용한 것 이외에는 합성예 1과 동일하게 하여 이미드화 중합체(이하, "중합체 4b"라 함) 26 g을 얻었다.26 g of imidized polymer (hereinafter, referred to as "polymer 4b") was obtained in the same manner as in Synthesis example 1 except that 32.7 g of polymer 4a was used instead of 31.2 g of polymer 1a.

비교 합성예 1Comparative Synthesis Example 1

폴리아미드산의Of polyamic acid 중합 polymerization

2,3,5-트리카르복시시클로펜틸아세트산 이무수물 0.1 몰(22.4 g)과 p-페닐렌디아민 0.1 몰(10.8 g)을 N-메틸-2-피롤리돈 300 g에 용해시켜 60 ℃에서 6 시간 반응시켰다. 계속해서, 반응 혼합물을 매우 과잉의 메탄올에 부어 반응 생성물을 침전시켰다. 그 후 메탄올로 세정하고, 감압하에 40 ℃에서 15 시간 건조시켜 폴리아미드산(이하, "중합체 Aa"라 함) 27 g을 얻었다. 0.1 mole (22.4 g) of 2,3,5-tricarboxycyclopentylacetic dianhydride and 0.1 mole (10.8 g) of p-phenylenediamine were dissolved in 300 g of N-methyl-2-pyrrolidone and 6 at 60 ° C. The reaction was time. The reaction mixture was then poured into very excess methanol to precipitate the reaction product. Then, the mixture was washed with methanol and dried at 40 ° C. under reduced pressure for 15 hours to obtain 27 g of polyamic acid (hereinafter referred to as “polymer Aa”).

이미드화Imidization 반응 reaction

16.6 g의 중합체 Aa에 N-메틸-2-피롤리돈 380 g, 피리딘 7.9 g 및 아세트산 무수물 10.2 g을 첨가하고 120 ℃에서 4 시간 이미드화 반응을 행하였다. 계속해서, 반응 혼합액을 매우 과잉의 메탄올에 부어 반응 생성물을 침전시켰다. 그 후 메탄올로 세정하고, 감압하에서 15 시간 건조시켜 이미드화 중합체(이하, "중합체 Ab"라 함) 13 g을 얻었다. 380 g of N-methyl-2-pyrrolidone, 7.9 g of pyridine and 10.2 g of acetic anhydride were added to 16.6 g of Polymer Aa, and an imidization reaction was performed at 120 ° C. for 4 hours. Subsequently, the reaction mixture was poured into an excessive amount of methanol to precipitate the reaction product. Thereafter, the mixture was washed with methanol and dried under reduced pressure for 15 hours to obtain 13 g of an imidized polymer (hereinafter referred to as "polymer Ab").

실시예 1Example 1

(1) 액정 배향제의 제조:(1) Preparation of liquid crystal aligning agent:

합성예 1에서 얻어진 중합체(1)를 γ-부티롤락톤에 용해시켜 고형분 농도 2.5 중량%의 용액을 만들고, 이 용액을 공경 1 ㎛의 필터로 여과하여 본 발명의 액정 배향제를 제조하였다. The polymer (1) obtained in Synthesis Example 1 was dissolved in γ-butyrolactone to make a solution having a solid content of 2.5% by weight, and the solution was filtered through a filter having a pore size of 1 μm to prepare a liquid crystal aligning agent of the present invention.

(2) 액정 표시 소자의 제조: (2) Preparation of Liquid Crystal Display Device:

1) 두께 1 mm의 유리 기판의 한 면에 설치된 ITO 막을 포함하는 투명 도전막상에, 상기한 바와 같이 하여 제조된 본 발명의 액정 배향제를 스피너를 이용하여 도포하고 180 ℃에서 1 시간 건조함으로써 건조막 두께 800 옹스트롬의 도막을 형성하였다. 1) A liquid crystal aligning agent of the present invention prepared as described above was applied on a transparent conductive film comprising an ITO film provided on one side of a glass substrate having a thickness of 1 mm using a spinner and dried by drying at 180 ° C. for 1 hour. A film of 800 angstroms in thickness was formed.

2) 형성된 도막면을 나일론제의 천을 감은 롤을 갖는 러빙기를 이용하여 러빙 처리를 행함으로써 액정 배향막을 제조하였다. 여기서 러빙 처리 조건은 롤 회전수 500 rpm, 스테이지 이동 속도 1 cm/초로 하였다. 2) The liquid crystal aligning film was manufactured by performing the rubbing process on the formed coating film surface using the rubbing machine which has the roll which rolled the cloth made from nylon. The rubbing treatment conditions were made into roll rotation speed 500 rpm and stage movement speed of 1 cm / sec.

3) 상기한 바와 같이 하여 액정 배향막이 형성된 기판을 2장 제조하고, 각각의 기판의 외연부에 직경 17 ㎛의 산화 알루미늄 구를 함유하는 에폭시 수지계 접착제를 스크린 인쇄법에 의해 도포한 후, 각각의 액정 배향막에서의 러빙 방향이 상호 역평행하게 되도록 2장의 기판을 간극을 통해 대향 배치하고, 외연부끼리를 접촉시키고 압착하여 접착제를 경화시켰다. 3) Two board | substrates with a liquid crystal aligning film were manufactured as mentioned above, and after apply | coating the epoxy resin adhesive containing the aluminum oxide sphere of diameter 17micrometer by the screen printing method to the outer edge part of each board | substrate, Two board | substrates were opposingly arranged through the space | interval so that the rubbing direction in a liquid crystal aligning film might mutually parallel, and the outer edge part contacted and crimped | cured and hardened the adhesive agent.

4) 기판의 표면 및 외연부의 접착제에 의해 구획된 셀갭 내에 네마틱형 액정 "MLC-6608"(메르크사제)을 주입 충전하고, 계속해서 주입 구멍을 에폭시계 접착제로 봉지하여 액정 셀을 구성하였다. 그 후 액정 셀의 외표면에 편광 방향이 액정 배향막의 러빙 방향과 45도 각도를 이루고, 또한 상호 직교하도록 편광판을 접합시킴으로써 액정 표시 소자를 제조하였다. 4) A nematic liquid crystal "MLC-6608" (manufactured by Merck Co., Ltd.) was filled and filled into the cell gap partitioned by the adhesive on the surface of the substrate and the outer edge portion, and then the injection hole was sealed with an epoxy adhesive to constitute a liquid crystal cell. Then, the liquid crystal display element was manufactured by bonding a polarizing plate to the outer surface of a liquid crystal cell so that a polarization direction may make an angle of 45 degree with the rubbing direction of a liquid crystal aligning film, and may orthogonally cross.

5) 상기한 바와 같이 하여 제조된 액정 표시 소자에서 액정의 프리틸트각은 89도였다. 또한, 액정 셀에 전압을 인가 및 해제했을 때 이상(異常) 도메인은 인정되지 않고, 액정 배향성은 양호하였다. 5) The pretilt angle of the liquid crystal was 89 degrees in the liquid crystal display element manufactured as mentioned above. Moreover, when a voltage was applied and released to the liquid crystal cell, the abnormal domain was not recognized and the liquid crystal alignment property was good.

실시예 2 내지 실시예 4Examples 2-4

중합체 (1b) 대신에 합성예 2 내지 4에서 얻어진 중합체 (2b) 내지 (4b)를 사용한 것 이외에는 실시예 1과 동일하게 하여 액정 표시 소자를 제조하였다. 제조된 액정 셀의 액정 배향성 및 프리틸트각을 평가하였다. 결과를 하기 표 1에 나타낸다. A liquid crystal display device was produced in the same manner as in Example 1 except that the polymers (2b) to (4b) obtained in Synthesis Examples 2 to 4 were used instead of the polymer (1b). The liquid crystal orientation and the pretilt angle of the produced liquid crystal cell were evaluated. The results are shown in Table 1 below.

실시예 5Example 5

중합체 (1b) 대신에 합성예 4에서 얻어진 중합체 (4a)를 사용한 것 이외에는 실시예 1과 동일하게 하여 액정 표시 소자를 제조하였다. 제조된 액정 셀의 액정 배향성 및 프리틸트각을 평가하였다. 결과를 표 1에 나타낸다. A liquid crystal display device was produced in the same manner as in Example 1 except that the polymer (4a) obtained in Synthesis Example 4 was used instead of the polymer (1b). The liquid crystal orientation and the pretilt angle of the produced liquid crystal cell were evaluated. The results are shown in Table 1.

Figure pat00016
Figure pat00016

비교예Comparative example

중합체 (1b) 대신에 비교 합성예 1에서 얻어진 중합체 (Ab)를 사용한 것 이외에는 실시예 1과 동일하게 하여 액정 표시 소자를 제조하였다. 제조된 액정 표시 소자의 액정의 프리틸트각은 1도 이하이고, 수직 배향하고 있지 않았다. A liquid crystal display device was produced in the same manner as in Example 1 except that the polymer (Ab) obtained in Comparative Synthesis Example 1 was used instead of the polymer (1b). The pretilt angle of the liquid crystal of the manufactured liquid crystal display element was 1 degree or less, and was not vertically oriented.

[발명의 효과][Effects of the Invention]

본 발명에 따르면, 액정 배향막으로 하였을 때 액정의 수직 배향성이 양호한 액정 배향막을 형성할 수 있는 수직 배향형 액정 표시 소자에 바람직한 액정 배향제를 제공할 수 있다. According to this invention, when it is set as a liquid crystal aligning film, the liquid crystal aligning agent suitable for the vertically-aligned liquid crystal display element which can form the liquid crystal aligning film with favorable vertical alignment property of a liquid crystal can be provided.

Claims (3)

하기 화학식 1로 나타내지는 구조, 및 하기 화학식 2로 나타내지는 구조로 이루어지는 군으로부터 선택되는 1개 이상의 구조를 측쇄에 갖는 중합체를 함유하는 것을 특징으로 하는 액정 배향제.
<화학식 1>
Figure pat00017

식 중, A1 및 B1은 불소 원자이다.
<화학식 2>
Figure pat00018
A liquid crystal aligning agent containing a polymer having at least one structure selected from the group consisting of a structure represented by the following formula (1) and a structure represented by the following formula (2) in the side chain.
<Formula 1>
Figure pat00017

In the formula, A 1 and B 1 are fluorine atoms.
<Formula 2>
Figure pat00018
제 1 항에 있어서, 중합체가 하기 화학식 3으로 나타내지는 기를 측쇄에 갖는 중합체인 액정 배향제.
<화학식 3>
Figure pat00019

식 중, P는 단결합, -O-, -COO- 또는 -CONH-이고, Q는 상기 화학식 1로 나타내지는 구조 또는 상기 화학식 2로 나타내지는 구조이며, R1은 2가의 지환족기이고, R2는 탄소수가 1 내지 22인 직쇄상 알킬기이다.
The liquid crystal aligning agent according to claim 1, wherein the polymer is a polymer having a group represented by the following formula (3) in a side chain.
<Formula 3>
Figure pat00019

In the formula, P is a single bond, -O-, -COO- or -CONH-, Q is a structure represented by the formula (1) or a structure represented by the formula (2), R 1 is a divalent alicyclic group, R 2 is a linear alkyl group having 1 to 22 carbon atoms.
제 1 항 또는 제 2 항에 기재된 액정 배향제로부터 형성된 액정 배향막을 구비하여 이루어지는 것을 특징으로 하는 액정 표시 소자. The liquid crystal aligning film formed from the liquid crystal aligning agent of Claim 1 or 2 is provided, The liquid crystal display element characterized by the above-mentioned.
KR1020110004497A 2003-11-06 2011-01-17 Liquid Crystal Aligning Agent and Liquid Crystal Display Device KR101032520B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JPJP-P-2003-376792 2003-11-06
JP2003376792A JP4433150B2 (en) 2003-11-06 2003-11-06 Liquid crystal aligning agent and liquid crystal display element

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020040089639A Division KR101035438B1 (en) 2003-11-06 2004-11-05 Liquid Crystal Aligning Agent and Liquid Crystal Display Device

Publications (2)

Publication Number Publication Date
KR20110010833A true KR20110010833A (en) 2011-02-07
KR101032520B1 KR101032520B1 (en) 2011-05-04

Family

ID=34687727

Family Applications (2)

Application Number Title Priority Date Filing Date
KR1020040089639A KR101035438B1 (en) 2003-11-06 2004-11-05 Liquid Crystal Aligning Agent and Liquid Crystal Display Device
KR1020110004497A KR101032520B1 (en) 2003-11-06 2011-01-17 Liquid Crystal Aligning Agent and Liquid Crystal Display Device

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020040089639A KR101035438B1 (en) 2003-11-06 2004-11-05 Liquid Crystal Aligning Agent and Liquid Crystal Display Device

Country Status (3)

Country Link
JP (1) JP4433150B2 (en)
KR (2) KR101035438B1 (en)
TW (1) TWI346690B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI427121B (en) * 2006-09-01 2014-02-21 Jnc Corp Liquid crystal alignment agent, liquid crystal alignment film, and liquid crystal display element
KR101184319B1 (en) * 2009-01-29 2012-09-19 제이엔씨 주식회사 Alignment agent and liquid crystalline polyimide used therein

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05127167A (en) * 1991-11-07 1993-05-25 Fuji Photo Film Co Ltd Oriented film
JP4165062B2 (en) * 2001-12-18 2008-10-15 チッソ株式会社 Compound having difluoromethyleneoxy and polymer thereof

Also Published As

Publication number Publication date
KR101032520B1 (en) 2011-05-04
KR20050043686A (en) 2005-05-11
JP2005139288A (en) 2005-06-02
KR101035438B1 (en) 2011-05-18
TWI346690B (en) 2011-08-11
JP4433150B2 (en) 2010-03-17
TW200521207A (en) 2005-07-01

Similar Documents

Publication Publication Date Title
KR100433973B1 (en) Liquid Crystal Aligning Agent
JP5444690B2 (en) Liquid crystal aligning agent and liquid crystal display element
KR101444461B1 (en) Vertical alignment-type liquid crystal aligning agent and vertical alignment-type liquid crystal display device
KR101319806B1 (en) Liquid Crystal Aligning Agent and Liquid Crystal Display Device
KR20080097932A (en) Vertical alignment-type liquid crystal aligning agent and liquid crystal display device
JP2001296525A (en) Liquid crystal aligning agent and liquid crystal display device
KR20070008422A (en) Liquid crystal aligning agent and liquid crystal display device
KR20080097931A (en) Vertical alignment-type liquid crystal aligning agent and liquid crystal display device
KR20090131655A (en) Liquid crystal aligning agent and liquid crystal display device
JPH10333153A (en) Liquid crystal orienting agent
KR101450923B1 (en) Liquid crystal aligning agent and liquid crystal display
KR20070115780A (en) Liquid crystal aligning agent and liquid crystal display device
KR101161446B1 (en) Liquid Crystal Aligning Agent for Inkjet Application
KR101142311B1 (en) Liquid crystal aligning agent and in-plane switching mode liquid crystal display device
KR20080042014A (en) Liquid crystal aligning agent and liquid crystal display device
KR20100031078A (en) Liquid crystal aligning agent and liquid crystal display device
KR101017491B1 (en) Liquid crystal aligning agent and liquid crystal display device
KR100841868B1 (en) Liquid Crystal Aligning Agent and Liquid Crystal Display Device
KR100845091B1 (en) Vertical Alignment-Type Liquid Crystalline Aligning Agent
KR20090063143A (en) Liquid crystal aligning agent and liquid crystal display device
KR101492270B1 (en) Liquid crystal aligning agent, liquid crystal alignment film and liquid crystal display device
KR100773684B1 (en) Liquid Crystal Aligning Agent
KR20090063142A (en) Liquid crystal aligning agent and liquid crystal display device
KR20070121571A (en) Liquid crystal aligning agent and liquid crystal display device
KR101032520B1 (en) Liquid Crystal Aligning Agent and Liquid Crystal Display Device

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20140418

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20150422

Year of fee payment: 5